Surinder K. Batra - Publications

Affiliations: 
Biochemistry and Molecular Biology University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Cell Biology, Molecular Biology, Biochemistry, Oncology

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kisling SG, Natarajan G, Pothuraju R, Shah A, Batra SK, Kaur S. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics. Cancer Metastasis Reviews. PMID 34591244 DOI: 10.1007/s10555-021-09991-1  1
2021 Pothuraju R, Chaudhary S, Rachagani S, Kaur S, Roy HK, Bouvet M, Batra SK. Mucins, gut microbiota, and postbiotics role in colorectal cancer. Gut Microbes. 13: 1974795. PMID 34586012 DOI: 10.1080/19490976.2021.1974795  1
2021 Rauth S, Karmakar S, Shah A, Seshacharyulu P, Nimmakayala RK, Ganguly K, Bhatia R, Muniyan S, Kumar S, Dutta S, Lin C, Datta K, Batra SK, Ponnusamy MP. SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma. Molecular and Cellular Biology. MCB0013521. PMID 34570619 DOI: 10.1128/MCB.00135-21  1
2021 Cannon A, Thompson CM, Bhatia R, Kandy RRK, Solheim JC, Batra SK, Kumar S. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies. Biochimica Et Biophysica Acta. Reviews On Cancer. 188628. PMID 34560199 DOI: 10.1016/j.bbcan.2021.188628  1
2021 Ganguly K, Bhatia R, Rauth S, Kisling A, Atri P, Thompson C, Vengoji R, Krishn SR, Shinde D, Thomas V, Kaur S, Mallya K, Cox JL, Kumar S, Batra SK. MUC5AC serves as the nexus for β-catenin/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance. Gastroenterology. PMID 34534538 DOI: 10.1053/j.gastro.2021.09.017  1
2021 Mehraj U, Ganai RA, Macha MA, Hamid A, Zargar MA, Bhat AA, Nasser MW, Haris M, Batra SK, Alshehri B, Al-Baradie RS, Mir MA, Wani NA. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cellular Oncology (Dordrecht). PMID 34528143 DOI: 10.1007/s13402-021-00634-9  1
2021 Nallasamy P, Nimmakayala RK, Karmakar S, Leon F, Seshacharyulu P, Lakshmanan I, Rachagani S, Mallya K, Zhang C, Ly QP, Myers MS, Josh L, Grabow CE, Gautam SK, Kumar S, ... ... Batra SK, et al. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis. Gastroenterology. PMID 34418441 DOI: 10.1053/j.gastro.2021.08.023  1
2021 Fatima I, Barman S, Uppada J, Chauhan S, Rauth S, Rachagani S, Ponnusamy MP, Smith L, Talmon G, Singh AB, Batra SK, Dhawan P. MASTL regulates EGFR signaling to impact pancreatic cancer progression. Oncogene. PMID 34331012 DOI: 10.1038/s41388-021-01951-x  1
2021 Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Atri P, Müschen M, Tissot FLH, Miser J, ... ... Batra SK, et al. Protein phosphatase 2A as a therapeutic target in small cell lung cancer. Molecular Cancer Therapeutics. PMID 34253596 DOI: 10.1158/1535-7163.MCT-21-0013  0.01
2021 Kaushal JB, Bhatia R, Kanchan RK, Raut P, Mallapragada S, Ly QP, Batra SK, Rachagani S. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β. Cancers. 13. PMID 34206370 DOI: 10.3390/cancers13133105  1
2021 Roosan MR, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Chao J, Chen C, Nasser MW, Chirravuri-Venkata R, Jain M, Smith L, Yost SE, Reckamp KL, Pillai R, Arvanitis L, ... ... Batra SK, et al. Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients. Cancers. 13. PMID 34204917 DOI: 10.3390/cancers13112776  1
2021 Nimmakayala RK, Rauth S, Chirravuri Venkata R, Marimuthu S, Nallasamy P, Vengoji R, Lele SM, Rachagani S, Mallya K, Malafa MP, Ponnusamy MP, Batra SK. PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34172498 DOI: 10.1158/1078-0432.CCR-20-5020  1
2021 Zhao N, Wang F, Ahmed S, Liu K, Zhang C, Cathcart SJ, DiMaio DJ, Punsoni M, Guan B, Zhou P, Wang S, Batra SK, Bronich T, Hei TK, Lin C, et al. Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma. Frontiers in Oncology. 11: 616625. PMID 34094902 DOI: 10.3389/fonc.2021.616625  1
2021 Soldi R, Ghosh Halder T, Sampson S, Vankayalapati H, Weston A, Thode T, Bhalla Md K, Ng S, Rodriguez Del Villar R, Drenner K, Kaadige MR, Horrigan SK, Batra S, Salgia R, Sharma S. . The Journal of Pharmacology and Experimental Therapeutics. PMID 34006586 DOI: 10.1124/jpet.121.000634  1
2021 Polavaram NS, Dutta S, Islam R, Bag AK, Roy S, Poitz D, Karnes J, Hofbauer LC, Kohli M, Costello BA, Jimenez R, Batra SK, Teply BA, Muders MH, Datta K. Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases. Bone Research. 9: 24. PMID 33990538 DOI: 10.1038/s41413-021-00136-2  1
2021 Mallya K, Gautam SK, Aithal A, Batra SK, Jain M. Modeling pancreatic cancer in mice for experimental therapeutics. Biochimica Et Biophysica Acta. Reviews On Cancer. 188554. PMID 33945847 DOI: 10.1016/j.bbcan.2021.188554  1
2021 Samidurai A, Xi L, Das A, Iness AN, Vigneshwar NG, Li PL, Singla DK, Muniyan S, Batra SK, Kukreja RC. Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities. Pharmacology & Therapeutics. 107858. PMID 33895190 DOI: 10.1016/j.pharmthera.2021.107858  1
2021 Chaudhary S, Pothuraju R, Rachagani S, Siddiqui JA, Atri P, Mallya K, Nasser MW, Sayed Z, Lyden ER, Smith L, Gupta SD, Ralhan R, Lakshmanan I, Jones DT, Ganti AK, ... ... Batra SK, et al. Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring. Cancer Letters. PMID 33878394 DOI: 10.1016/j.canlet.2021.04.004  1
2021 Gurumurthy CB, O'Brien AR, Quadros RM, Adams J, Alcaide P, Ayabe S, Ballard J, Batra SK, Beauchamp MC, Becker KA, Bernas G, Brough D, Carrillo-Salinas F, Chan W, Chen H, et al. Response to correspondence on "Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation". Genome Biology. 22: 99. PMID 33827648 DOI: 10.1186/s13059-021-02320-3  1
2021 Marimuthu S, Rauth S, Ganguly K, Zhang C, Lakshmanan I, Batra SK, Ponnusamy MP. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer Metastasis Reviews. PMID 33813658 DOI: 10.1007/s10555-021-09959-1  1
2021 Poelaert BJ, Knoche SM, Larson AC, Pandey P, Seshacharyulu P, Khan N, Maurer HC, Olive KP, Sheinin Y, Ahmad R, Singh AB, Batra SK, Rachagani S, Solheim JC. Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer. Cancers. 13. PMID 33810510 DOI: 10.3390/cancers13071535  1
2021 Lakshmanan I, Chaudhary S, Vengoji R, Seshacharyulu P, Rachagani S, Carmicheal J, Jahan R, Atri P, Venkata Ramakanth C, Gupta R, Marimuthu S, Perumal N, Rauth S, Kaur S, Mallya K, ... ... Batra SK, et al. ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation. Molecular Oncology. PMID 33792183 DOI: 10.1002/1878-0261.12956  1
2021 Saxena S, Prajapati DR, Goel P, Tomar B, Hayashi Y, Atri P, Rachagani S, Grandgenett PM, Hollingsworth MA, Batra SK, Singh RK. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. Cancers. 13. PMID 33669221 DOI: 10.3390/cancers13040818  1
2021 Rauth S, Karmakar S, Batra SK, Ponnusamy MP. Recent advances in organoid development and applications in disease modeling. Biochimica Et Biophysica Acta. Reviews On Cancer. 188527. PMID 33640383 DOI: 10.1016/j.bbcan.2021.188527  1
2021 Bhat AA, Yousuf P, Wani NA, Rizwan A, Chauhan SS, Siddiqi MA, Bedognetti D, El-Rifai W, Frenneaux MP, Batra SK, Haris M, Macha MA. Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduction and Targeted Therapy. 6: 93. PMID 33637674 DOI: 10.1038/s41392-021-00503-9  1
2021 Karmakar S, Ponnusamy MP, Batra SK. Reply to the editor's letter: PAF1 regulates the stemness of pancreatic cancer stem cells. Gastroenterology. PMID 33548231 DOI: 10.1053/j.gastro.2021.02.003  1
2021 Kaja A, Adhikari A, Karmakar S, Zhang W, Rothschild G, Basu U, Batra SK, Davie JK, Bhaumik SR. Proteasomal regulation of mammalian SPT16 in controlling transcription. Molecular and Cellular Biology. PMID 33526453 DOI: 10.1128/MCB.00452-20  1
2021 Bhat AA, Yousuf P, Wani NA, Rizwan A, Chauhan SS, Siddiqi MA, Bedognetti D, El-Rifai W, Frenneaux MP, Batra SK, Haris M, Macha MA. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduction and Targeted Therapy. 6: 12. PMID 33436555 DOI: 10.1038/s41392-020-00419-w  1
2021 Shah A, Rauth S, Aithal A, Kaur S, Ganguly K, Orzechowski C, Varshney GC, Jain M, Batra SK. The Current Landscape of Antibody-based Therapies in Solid Malignancies. Theranostics. 11: 1493-1512. PMID 33391547 DOI: 10.7150/thno.52614  1
2020 Macha MA, Wani NA, Ganai RA, Bhat AA, Hamid A, Hashem S, Haris M, Chauhan SS, Zargar MA, Batra SK. Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy. Advances in Experimental Medicine and Biology. 1296: 11-31. PMID 34185284 DOI: 10.1007/978-3-030-59038-3_2  1
2020 Mallya K, Haridas D, Seshacharyulu P, Pothuraju R, Junker WM, Krishn SR, Muniyan S, Vengoji R, Batra SK, Rachagani S. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open. PMID 34004687 DOI: 10.1242/bio.052878  1
2020 Kaur S, Jain M, Batra SK. Liquid Biopsy for Identification of High-Risk Cystic Lesions of Pancreas. Gastroenterology. PMID 33385429 DOI: 10.1053/j.gastro.2020.12.039  1
2020 Kaushik G, Seshacharyulu P, Rauth S, Nallasamy P, Rachagani S, Nimmakayala RK, Vengoji R, Mallya K, Chirravuri-Venkata R, Singh AB, Foster JM, Ly QP, Smith LM, Lele SM, Malafa MP, ... ... Batra SK, et al. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Oncogene. PMID 33288882 DOI: 10.1038/s41388-020-01564-w  1
2020 Lei F, Xi X, Rachagani S, Seshacharyulu P, Talmon GA, Ponnusamy MP, Batra SK, Bronich TK. Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33217475 DOI: 10.1016/j.jconrel.2020.11.029  1
2020 Mohanty A, Nam A, Pozhitkov A, Yang L, Srivastava S, Nathan A, Wu X, Mambetsariev I, Nelson M, Subbalakshmi AR, Guo L, Arvanitis LD, Nasser MW, Batra SK, Orban J, et al. Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer. Iscience. 23: 101679. PMID 33134900 DOI: 10.1016/j.isci.2020.101679  1
2020 Ganguly K, Krishn SR, Rachagani S, Jahan R, Shah A, Nallasamy P, Rauth S, Atri P, Cox JL, Pothuraju R, Smith LM, Ayala S, Evans C, Ponusamy MP, Kumar S, ... ... Batra SK, et al. Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness. Cancer Research. PMID 33127746 DOI: 10.1158/0008-5472.CAN-20-1293  1
2020 Bhatia R, Muniyan S, Thompson CM, Kaur S, Jain M, Singh RK, Dhaliwal A, Cox JL, Akira S, Singh S, Batra SK, Kumar S. Neutrophil Gelatinase-Associated Lipocalin Protects Acinar Cells From Cerulein-Induced Damage During Acute Pancreatitis. Pancreas. 49: 1297-1306. PMID 33122517 DOI: 10.1097/MPA.0000000000001690  1
2020 Nimmakayala RK, Leon F, Rachagani S, Rauth S, Nallasamy P, Marimuthu S, Shailendra GK, Chhonker YS, Chugh S, Chirravuri R, Gupta R, Mallya K, Prajapati DR, Lele SM, C Caffrey T, ... ... Batra SK, et al. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Oncogene. PMID 33110235 DOI: 10.1038/s41388-020-01518-2  1
2020 Gautam SK, Kanchan RK, Siddiqui JA, Maurya SK, Rauth S, Perumal N, Atri P, Venkata RC, Mallya K, Mirza S, Ponnusamy MP, Band V, Mahapatra S, Jain M, Batra SK, et al. Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer. Cancers. 12. PMID 33019652 DOI: 10.3390/cancers12102838  1
2020 Mohanty A, Nam A, Pozhitkov A, Yang L, Srivastava S, Nathan A, Wu X, Mambetsariev I, Nelson M, Subbalakshmi AR, Guo L, Nasser MW, Batra SK, Orban J, Jolly MK, et al. A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer. Iscience. 23: 101496. PMID 32947124 DOI: 10.1016/J.Isci.2020.101496  1
2020 Batra SK, Cannon A, Thompson CM, Maurer C, Atri P, Bhatia R, West S, Ghersi D, Olive KP, Kumar S. CXCR3 and Cognate Ligands Are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32873571 DOI: 10.1158/1078-0432.Ccr-20-1359  1
2020 Muniyan S, Rachagani S, Parte S, Halder S, Seshacharyulu P, Kshirsagar P, Siddiqui JA, Vengoji R, Rauth S, Islam R, Mallya K, Datta K, Xi L, Das A, Teply BA, ... ... Batra SK, et al. Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO-cGMP signaling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32847934 DOI: 10.1158/1078-0432.Ccr-20-1569  1
2020 Bhatia R, Thompson C, Ganguly K, Singh S, Batra SK, Kumar S. Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis. Cells. 9. PMID 32796685 DOI: 10.3390/Cells9081880  1
2020 Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Batra SK, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009  1
2020 Karmakar S, Rauth S, Nallasamy P, Perumal N, Nimmakalaya RK, Leon F, Gupta R, Barkeer S, Venkata RC, Raman V, Rachagani S, Ponnusamy MP, Batra SK. PAF1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions with PHF5A and DDX3. Gastroenterology. PMID 32781084 DOI: 10.1053/J.Gastro.2020.07.053  1
2020 Liu L, Kshirsagar P, Christiansen J, Gautam SK, Aithal A, Gulati M, Kumar S, Solheim JC, Batra SK, Jain M, Wannemuehler MJ, Narasimhan B. Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β. Journal of Biomedical Materials Research. Part A. PMID 32776461 DOI: 10.1002/Jbm.A.37080  1
2020 Chaudhary S, Dam V, Ganguly K, Sharma S, Atri P, Chirravuri R, Cox JL, Sayed Z, Jones DT, Ganti AK, Ghersi D, Macha MA, Batra SK. Differential mutation spectrum and immune landscape in African Americans versus whites: A possible determinant to health disparity in head and neck cancer. Cancer Letters. PMID 32738272 DOI: 10.1016/J.Canlet.2020.07.029  1
2020 Mallya K, Haridas D, Seshacharyulu P, Pothuraju R, Junker WM, Krishn SR, Muniyan S, Vengoji R, Batra SK, Rachagani S. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open. PMID 32709695 DOI: 10.1242/Bio.052878  1
2020 Muniyan S, Xi L, Datta K, Das A, Teply BA, Batra SK, Kukreja RC. Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients. Biochimica Et Biophysica Acta. Reviews On Cancer. 188383. PMID 32535158 DOI: 10.1016/J.Bbcan.2020.188383  1
2020 Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Biomarkers and Strategy to Detect Pre-Invasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32532830 DOI: 10.1158/1055-9965.Epi-20-0161  1
2020 Osna NA, Bhatia R, Thompson C, Batra SK, Kumar S, Cho Y, Szabo G, Molina PE, Weinman SA, Ganesan M, Kharbanda KK. Role of Non-Genetic Risk Factors in Exacerbating Alcohol-Related Organ Damage. Alcohol (Fayetteville, N.Y.). PMID 32497558 DOI: 10.1016/J.Alcohol.2020.05.002  1
2020 Ganguly K, Rauth S, Marimuthu S, Kumar S, Batra SK. Unraveling mucin domains in cancer and metastasis: when protectors become predators. Cancer Metastasis Reviews. PMID 32488403 DOI: 10.1007/S10555-020-09896-5  1
2020 Awaji M, Saxena S, Wu L, Prajapati DR, Purohit A, Varney ML, Kumar S, Rachagani S, Ly QP, Jain M, Batra SK, Singh RK. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32453916 DOI: 10.1096/Fj.201902990R  1
2020 Chen BT, Chen Z, Ye N, Mambetsariev I, Fricke J, Daniel E, Wang G, Wong CW, Rockne RC, Colen RR, Nasser MW, Batra SK, Holodny AI, Sampath S, Salgia R. Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach. Frontiers in Oncology. 10: 593. PMID 32391274 DOI: 10.3389/Fonc.2020.00593  0.01
2020 Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for Early Detection of Colorectal Cancer:The Early Detection Research Network, a Framework for Clinical Translation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32299850 DOI: 10.1158/1055-9965.Epi-20-0234  1
2020 Jahan R, Shah A, Kisling SG, Macha MA, Thayer S, Batra SK, Kaur S. Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications. Biochimica Et Biophysica Acta. Reviews On Cancer. 188362. PMID 32298747 DOI: 10.1016/J.Bbcan.2020.188362  1
2020 Mirzapoiazova T, Pozhitkov A, Nam A, Mambetsariev I, Nelson MS, Tan YC, Zhang K, Raz D, Singhal S, Nasser MW, Kulkarni P, Batra SK, Sattler M, Salgia R. Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines. International Journal of Oncology. PMID 32236606 DOI: 10.3892/Ijo.2020.5034  1
2020 Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: Intersections between affected organs, mediators, and pharmacological interventions. Biochimica Et Biophysica Acta. Reviews On Cancer. 188359. PMID 32222610 DOI: 10.1016/J.Bbcan.2020.188359  1
2020 Pothuraju R, Krishn SR, Gautam SK, Pai P, Ganguly K, Chaudhary S, Rachagani S, Kaur S, Batra SK. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. Cancers. 12. PMID 32168759 DOI: 10.3390/Cancers12030649  1
2020 Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel D, Donson AM, Perry D, Punsoni M, Talmon G, Coulter DW, Boue DR, Snuderl M, Nasser MW, Batra SK, et al. MiR-1253 exerts tumor suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain Pathology (Zurich, Switzerland). PMID 32145124 DOI: 10.1111/Bpa.12829  1
2020 Pothuraju R, Rachagani S, Krishn SR, Chaudhary S, Nimmakayala RK, Siddiqui JA, Ganguly K, Lakshmanan I, Cox JL, Mallya K, Kaur S, Batra SK. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Molecular Cancer. 19: 37. PMID 32098629 DOI: 10.1186/S12943-020-01156-Y  1
2020 Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Oncotarget. 11: 304. PMID 32076492 DOI: 10.18632/Oncotarget.27450  1
2020 Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis. Cells. 9. PMID 32075174 DOI: 10.3390/Cells9020446  1
2020 Kanchan RK, Siddiqui JA, Mahapatra S, Batra SK, Nasser MW. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy. Molecular Cancer. 19: 29. PMID 32059676 DOI: 10.1186/S12943-020-1140-X  1
2020 Mambetsariev I, Wang Y, Chen C, Nadaf S, Pharaon R, Fricke J, Amanam I, Amini A, Bild A, Chu P, Erhunmwunsee L, Kim J, Munu J, Pillai R, Raz D, ... ... Batra SK, et al. Precision medicine and actionable alterations in lung cancer: A single institution experience. Plos One. 15: e0228188. PMID 32045431 DOI: 10.1371/Journal.Pone.0228188  1
2020 Challa S, Husain K, Kim R, Coppola D, Batra SK, Cheng JQ, Malafa MP. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer. Translational Oncology. 13: 481-489. PMID 32004866 DOI: 10.1016/J.Tranon.2019.11.009  1
2020 Yokoyama S, Hamada T, Higashi M, Matsuo K, Maemura K, Kurahara H, Horinouchi M, Hiraki T, Sugimoto T, Akahane T, Yonezawa S, Kornmann M, Batra SK, Hollingsworth MA, Tanimoto A. Predicted Prognosis of Pancreatic Cancer Patients by Machine Learning. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31992588 DOI: 10.1158/1078-0432.Ccr-19-1247  1
2020 Gautam SK, Kumar S, Dam V, Ghersi D, Jain M, Batra SK. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Seminars in Immunology. 101391. PMID 31952903 DOI: 10.1016/J.Smim.2020.101391  1
2020 Carmicheal J, Atri P, Sharma S, Kumar S, Chirravuri Venkata R, Kulkarni P, Salgia R, Ghersi D, Kaur S, Batra SK. Presence and structure-activity relationship of intrinsically disordered regions across mucins. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 31908009 DOI: 10.1096/Fj.201901898Rr  1
2020 Cannon A, Thompson CM, Atri P, Bhatia R, Kumar S, Batra S. Analysis of associations of CXCR3 ligands with immune microenvironment and aggressiveness in murine and human pancreatic ductal adenocarcinoma. Journal of Clinical Oncology. 38: 762-762. DOI: 10.1200/Jco.2020.38.4_Suppl.762  0.01
2020 Thompson CM, Cannon A, Kshirsagar P, Bhatia R, Batra S, Kumar S. Clinical significance of MUC4 isoforms in pancreatic cancer patients. Journal of Clinical Oncology. 38: 742-742. DOI: 10.1200/Jco.2020.38.4_Suppl.742  0.01
2020 Chaudhary S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Abstract A31: Deregulation of NOTCH 1/NR4A2 signaling axis in head and neck cancer pathogenesis Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A31  1
2020 Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y. Abstract A44: PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-A44  1
2020 Palanivel C, Gabler BM, Yan Y, Batra SK, Ouellette MM. Abstract A32: The small GTPase Rac1 controls the stability of Yes-Associated Protein (YAP) independently of the LATS1/2 kinases Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-A32  1
2020 Marimuthu S, Lakshmanan I, Muniyan S, Atri P, Jain M, Ponnusamy MP, Batra SK. Abstract 6072: MUC16-Cter cleavage increases the metastatic potential in pancreatic cancer Cancer Research. 80: 6072-6072. DOI: 10.1158/1538-7445.Am2020-6072  1
2020 Leon F, Nimmakayala RK, Chugh S, Gupta R, Rachagani S, Batra SK, Ponnusamy MP. Abstract 6030: Role of immature CD44 o-glycosylation in enrichment of cancer stem cell population for aggressive pancreatic cancer Cancer Research. 80: 6030-6030. DOI: 10.1158/1538-7445.Am2020-6030  1
2020 Shah A, Aithal A, Orzechowski C, Marimuthu S, Kshirsagar P, Ponnusamy MP, Jain M, Batra SK. Abstract 2289: Evaluation of novel genetically engineered anti-MUC16 antibody for therapeutic targeting in pancreatic cancer Immunology. DOI: 10.1158/1538-7445.Am2020-2289  1
2019 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochimica Et Biophysica Acta. Reviews On Cancer. 188318. PMID 31676330 DOI: 10.1016/J.Bbcan.2019.188318  1
2019 Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, ... Batra SK, et al. A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study. Cancer Treatment and Research Communications. 22: 100162. PMID 31675535 DOI: 10.1016/J.Ctarc.2019.100162  1
2019 Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y, Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kang C, Choudhary G, Gordon-Mitchell S, Aluri S, Bhattacharyya S, Sahu S, ... ... Batra S, et al. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 8. PMID 31663852 DOI: 10.7554/Elife.50663  1
2019 Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Oncogenesis. 8: 63. PMID 31659153 DOI: 10.1038/s41389-019-0172-9  1
2019 West S, Kumar S, Batra SK, Ali H, Ghersi D. Uncovering and characterizing splice variants associated with survival in lung cancer patients. Plos Computational Biology. 15: e1007469. PMID 31652257 DOI: 10.1371/Journal.Pcbi.1007469  1
2019 Mirzapoiazova T, Li H, Nathan A, Srivstava S, Nasser MW, Lennon F, Armstrong B, Mambetsariev I, Chu PG, Achuthan S, Batra SK, Kulkarni P, Salgia R. Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells. Journal of Clinical Medicine. 8. PMID 31635288 DOI: 10.3390/Jcm8101723  1
2019 Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Letters. PMID 31629933 DOI: 10.1016/J.Canlet.2019.10.023  1
2019 Parte S, Virant-Klun I, Patankar M, Batra SK, Straughn A, Kakar SS. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer. Stem Cell Reviews and Reports. PMID 31482269 DOI: 10.1007/S12015-019-09911-5  1
2019 Gurumurthy CB, O'Brien AR, Quadros RM, Adams J, Alcaide P, Ayabe S, Ballard J, Batra SK, Beauchamp MC, Becker KA, Bernas G, Brough D, Carrillo-Salinas F, Chan W, Chen H, et al. Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation. Genome Biology. 20: 171. PMID 31446895 DOI: 10.1186/S13059-019-1776-2  1
2019 Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP. Cancer Cell International. 19: 189. PMID 31367187 DOI: 10.1186/S12935-019-0876-0  1
2019 Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC. Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. Scientific Reports. 9: 11117. PMID 31366895 DOI: 10.1038/S41598-019-47308-Z  1
2019 Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R. Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology. Journal of Clinical Medicine. 8. PMID 31315252 DOI: 10.3390/Jcm8071038  1
2019 Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer. 10: 52-62. PMID 31258832 DOI: 10.18632/Genesandcancer.189  1
2019 Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Journal of Experimental & Clinical Cancer Research : Cr. 38: 266. PMID 31215502 DOI: 10.1186/S13046-019-1264-2  1
2019 Hollandsworth HM, Lwin TM, Amirfakhri S, Filemoni F, Batra SK, Hoffman RM, Dhawan P, Bouvet M. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models. The Journal of Surgical Research. 242: 145-150. PMID 31077946 DOI: 10.1016/J.Jss.2019.04.048  1
2019 Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Ebiomedicine. PMID 30956167 DOI: 10.1016/J.Ebiom.2019.03.056  1
2019 Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis. Oncogene. PMID 30914801 DOI: 10.1038/S41388-019-0791-9  1
2019 Hall BR, Cannon A, Thompson C, Santhamma B, Chavez-Riveros A, Bhatia R, Nair HB, Nickisch K, Batra SK, Kumar S. Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma. Genes & Cancer. 10: 1-10. PMID 30899415 DOI: 10.18632/Genesandcancer.184  1
2019 Lei F, Xi X, Batra SK, Bronich TK. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer. The Journal of Pharmacology and Experimental Therapeutics. PMID 30796131 DOI: 10.1124/Jpet.118.255786  1
2019 Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Scientific Reports. 9: 123. PMID 30644396 DOI: 10.1038/S41598-018-36328-W  1
2019 Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Reviews. PMID 30618016 DOI: 10.1007/S10555-018-09775-0  1
2019 Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. Journal of the National Cancer Institute. PMID 30615137 DOI: 10.1093/Jnci/Djy207  1
2019 Shehan J, Gupta S, Vengoji R, Rachagani S, Zhang Y, Mallya K, Kaur S, Jain M, White M, Aizenberg M, McComb R, Smith L, Cohen M, Batra S, Shonka NA. Mmp-2 And Ngal As Biomarkers In Glioblastoma: A Pilot Study Medical Research Archives. 7. DOI: 10.18103/Mra.V7I6.1934  1
2019 Ganguly K, Krishn SR, Jahan R, Atri P, Rachagani S, Rauth S, Xi H, Lu Y, Batra S, Kaur S. Abstract 65: Gel-forming mucin MUC5AC as the nexus for cell-adhesion molecules governing pancreatic cancer aggressiveness and chemoresistance Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-65  1
2019 Atri P, Seshacharyulu P, Rachagani S, Nallasamy P, Rauth S, Kaushik G, Ganguly K, Ghersi D, Ponnusamy MP, Kaur S, Batra SK. Abstract 4804: Pre-clinical development of ISOX; A novel therapy for pancreatic cancer identified utilizing system biology approach(s) Cancer Research. 79: 4804-4804. DOI: 10.1158/1538-7445.Sabcs18-4804  1
2019 Rauth S, Karmakar S, Shah A, Nimmakayala RK, Bhatia R, Muniyan S, Kumar S, Dutta S, Datta K, Batra SK, Ponnusamy MP. Abstract 4438: Role of post translational modification of PAF1/PD2 in gemcitabine resistance of pancreatic cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4438  1
2019 Karmakar S, Rauth S, Nimmakayala RK, Barkeer S, Nasser MW, Rachagani S, Ghersi D, Ponnusamy MP, Batra SK. Abstract 3679: A novel mechanism for pancreatic cancer stem cell maintenance: PAF1C-independent role of PAF1 Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3679  1
2019 Challagundla KB, Reynolds P, Gorantla S, Poluektova L, Coulter D, Batra SK, Chava S. Abstract 781: The tumor suppressive microRNA-15 family targets MYCN in neuroblastoma Cancer Research. 79: 781-781. DOI: 10.1158/1538-7445.Am2019-781  1
2019 Vengoji R, Macha MA, Nimmakayala R, Rachagani S, Mallya K, Jain M, Ponnusamy MP, Batra SK, Shonka N. Abstract 4684: Afatinib targets glioblastoma stem cells by inhibiting EGFRVIII-cMet co-activation Cancer Research. 79: 4684-4684. DOI: 10.1158/1538-7445.Am2019-4684  1
2019 Kshirsagar P, Rachagani S, Seshacharyulu P, Muniyan S, Sharma S, Mahato R, Batra SK, Jain M. Abstract 2583: DNA-linked gold nanoprobe assay: An efficient technology for direct and high-sensitive quantification of serum microRNAs in prostate cancer Cancer Research. 79: 2583-2583. DOI: 10.1158/1538-7445.Am2019-2583  1
2019 Fatima I, Chauhan SS, Uppada SB, Talmon GA, Singh AB, Batra SK, Dhawan P. Abstract 2541: Mastl regulates EGFR signaling to promote pancreatic cancer progression Cancer Research. 79: 2541-2541. DOI: 10.1158/1538-7445.Am2019-2541  1
2019 Gautam SK, Kanchan R, Atri P, Siddiqui J, Rauth S, Mahapatra S, Jain M, Moorthy PP, Salgia R, Band V, Batra SK, Nasser MW. Abstract 2017: Blocking ErbB-c-Met-FAK signaling axis suppresses brain metastasis of breast cancer Cancer Research. 79: 2017-2017. DOI: 10.1158/1538-7445.Am2019-2017  1
2019 Awaji M, Varney M, Purohit A, Wu L, Saxena S, Kumar S, Batra SK, Singh RK. Abstract 1982: Sustained CXCR2 signaling promotes secretory phenotype in cancer-associated fibroblasts of pancreatic cancer via activation of NFkB Cancer Research. 79: 1982-1982. DOI: 10.1158/1538-7445.Am2019-1982  1
2019 Saxena S, Tomar B, Wu L, Awaji M, Rachagani S, Ouellette MJ, Batra SK, Dave BJ, Singh RK. Abstract 1725: Mutationally activated KRAS(G12D) upregulates the expression of axonal guidance cue Semaphorin-5A in pancreatic cancer Cancer Research. 79: 1725-1725. DOI: 10.1158/1538-7445.Am2019-1725  1
2019 Kanchan R, Perumal NK, Atri P, Thapa I, Nasser MW, Perry D, Batra SK, Mahapatra S. MEDU-08. MiR-1253 POSSESSES NOVEL TUMOR SUPPRESSOR PROPERTIES IN PEDIATRIC MEDULLOBLASTOMA Neuro-Oncology. 21: ii104-ii105. DOI: 10.1093/Neuonc/Noz036.168  0.01
2018 Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 294: 237-246. PMID 30576747 DOI: 10.1016/J.Jconrel.2018.12.031  1
2018 Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research : Cr. 37: 319. PMID 30567565 DOI: 10.1186/S13046-018-0963-4  1
2018 Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain M, Lyubchenko YL, Lu Y, Batra SK, Kaur S. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic Cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30550805 DOI: 10.1016/J.Nano.2018.11.008  1
2018 Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA. Novel Therapies Hijack the Blood Brain Barrier to Eradicate Glioblastoma Cancer Stem Cells. Carcinogenesis. PMID 30475990 DOI: 10.1093/Carcin/Bgy171  1
2018 Barkeer S, Chugh S, Karmakar S, Kaushik G, Rauth S, Rachagani S, Batra SK, Ponnusamy MP. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. Bmc Cancer. 18: 1157. PMID 30466404 DOI: 10.1186/S12885-018-5074-2  1
2018 Zheng L, Li H, Cannon A, Trease AJ, Spagnol G, Zheng H, Radio S, Patel K, Batra S, Sorgen PL. Phosphorylation of Cx43 residue Y313 by Src contributes to blocking the interaction with Drebrin and disassembling gap junctions. Journal of Molecular and Cellular Cardiology. PMID 30448479 DOI: 10.1016/J.Yjmcc.2018.11.008  1
2018 Nimmakayala RK, Batra SK, Ponnusamy MP. Unraveling the journey of cancer stem cells from origin to metastasis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 50-63. PMID 30419314 DOI: 10.1016/J.Bbcan.2018.10.006  1
2018 Carmicheal J, Kaur S, Batra SK, Ganti AK. Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer. Translational Lung Cancer Research. 7: S254-S257. PMID 30393616 DOI: 10.21037/Tlcr.2018.09.06  1
2018 Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Y, et al. Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma. Cancer Biology & Therapy. 1-10. PMID 30311833 DOI: 10.1080/15384047.2018.1472193  1
2018 Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C. A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality. Annals of Surgery. PMID 30188400 DOI: 10.1097/Sla.0000000000003042  1
2018 Parte SC, Batra SK, Kakar SS. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors. Journal of Ovarian Research. 11: 69. PMID 30121075 DOI: 10.1186/S13048-018-0439-3  1
2018 Datta K, Roy S, Bag AK, Dutta S, Polavaram NS, Islam R, Schellenburg S, Banwait JK, Guda C, Ran S, Hollingsworth MA, Singh RK, Talmadge JE, Muders MH, Batra SK. Macrophage-derived Neuropilin-2 exhibits novel tumor-promoting functions. Cancer Research. PMID 30111533 DOI: 10.1158/0008-5472.Can-18-0562  1
2018 Cannon A, Thompson C, Hall BR, Jain M, Kumar S, Batra SK. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. Genes & Cancer. 9: 78-86. PMID 30108679 DOI: 10.18632/Genesandcancer.171  1
2018 Chugh S, Barkeer S, Rachagani S, Nimmakayala RK, Perumal N, Pothuraju R, Atri P, Mahapatra S, Thapa I, Talmon GA, Smith LM, Yu X, Neelamegham S, Fu J, Xia L, ... ... Batra SK, et al. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice. Gastroenterology. PMID 30086262 DOI: 10.1053/J.Gastro.2018.08.007  1
2018 Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB, Dhawan P. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling. Molecular Cancer. 17: 111. PMID 30068336 DOI: 10.1186/S12943-018-0848-3  1
2018 Barkeer S, Chugh S, Batra SK, Ponnusamy MP. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. Neoplasia (New York, N.Y.). 20: 813-825. PMID 30015157 DOI: 10.1016/J.Neo.2018.06.001  1
2018 Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK. MUC16 as a Novel Target for Cancer Therapy. Expert Opinion On Therapeutic Targets. PMID 29999426 DOI: 10.1080/14728222.2018.1498845  1
2018 Nimmakayala RK, Seshacharyulu P, Lakshmanan I, Rachagani S, Chugh S, Karmakar S, Rauth S, Vengoji R, Atri P, Talmon GA, Lele SM, Smith LM, Thapa I, Bastola D, Ouellette MM, ... Batra SK, et al. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Gastroenterology. PMID 29864419 DOI: 10.1053/J.Gastro.2018.05.041  1
2018 Jahan R, Macha MA, Rachaghani S, Das S, Smith LM, Kaur S, Batra SK. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway. Biochimica Et Biophysica Acta. PMID 29777904 DOI: 10.1016/J.Bbadis.2018.05.008  1
2018 Vengoji R, Macha MA, Batra SK, Shonka NA. Natural products: a hope for glioblastoma patients. Oncotarget. 9: 22194-22219. PMID 29774132 DOI: 10.18632/Oncotarget.25175  1
2018 Kaushik G, Ponnusamy MP, Batra SK. Current Status of 3-D Organoids as Pre-Clinical Models. Stem Cells (Dayton, Ohio). PMID 29770526 DOI: 10.1002/Stem.2852  1
2018 Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK. Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. Oncotarget. 9: 19396-19405. PMID 29721211 DOI: 10.18632/Oncotarget.25036  1
2018 Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer. Plos One. 13: e0193907. PMID 29708979 DOI: 10.1371/Journal.Pone.0193907  1
2018 Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, et al. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Digestive Diseases and Sciences. PMID 29572615 DOI: 10.1007/S10620-018-5000-0  1
2018 Cruz E, Kumar S, Yuan L, Arikkath J, Batra SK. Intracellular amyloid beta expression leads to dysregulation of the mitogen-activated protein kinase and bone morphogenetic protein-2 signaling axis. Plos One. 13: e0191696. PMID 29470488 DOI: 10.1371/Journal.Pone.0191696  1
2018 Saxena S, Hayashi Y, Wu L, Awaji M, Atri P, Varney ML, Purohit A, Rachagani S, Batra SK, Singh RK. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget. 9: 5931-5943. PMID 29464045 DOI: 10.18632/Oncotarget.23644  1
2018 Ingersoll MA, Chou YW, Lin JS, Yuan TC, Miller D, Xie Y, Tu Y, Oberley-Deegan RE, Batra SK, Lin MF. p66Shc regulates migration of castration-resistant prostate cancer cells. Cellular Signalling. PMID 29462661 DOI: 10.1016/J.Cellsig.2018.02.008  1
2018 Qazi AK, Siddiqui JA, Jahan R, Chaudhary S, Walker LA, Syed Z, Jones DT, Batra SK, Macha MA. Emerging Therapeutic Potential of Graviola and its Constituents in Cancers. Carcinogenesis. PMID 29462271 DOI: 10.1093/Carcin/Bgy024  1
2018 Krishn SR, Ganguly K, Kaur S, Batra SK. Ramifications of Secreted Mucin MUC5AC in Malignant Journey: A Holistic View. Carcinogenesis. PMID 29415129 DOI: 10.1093/Carcin/Bgy019  1
2018 Karmakar S, Dey P, Vaz AP, Bhaumik SR, Ponnusamy MP, Batra SK. PD2/PAF1 at the Crossroads of the Cancer Network. Cancer Research. PMID 29311159 DOI: 10.1158/0008-5472.Can-17-2175  1
2018 Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R. Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma. Cancer Biology & Therapy. 0. PMID 29303405 DOI: 10.1080/15384047.2017.1416937  1
2018 Etekpo A, Alghawalby A, Alghawalby M, Soliman AS, Hablas A, Chen B, Batra S, Soliman GA. Differences in MUC4 Expression in Pancreatic Cancers and Pancreatic Cysts in Egypt Journal of Carcinogenesis & Mutagenesis. 9. DOI: 10.4172/2157-2518.1000312  0.01
2018 Awaji M, Varney M, Purohit A, Batra S, Singh R. Abstract 5085: CXCR2 signaling in pancreatic cancer induces a tumor supporting inflammatory phenotype of the cancer-associated fibroblasts Cancer Research. 78: 5085-5085. DOI: 10.1158/1538-7445.Am2018-5085  1
2018 Palanivel C, Gabler B, Yan Y, Batra SK, Ouellette MM. Abstract 4366: The small GTPase Rac1 controls the stability of the Yes-associated protein 1 (YAP1) independently of the LATS1/2 kinases and SCF-βTRCP ubiquitin ligase Cancer Research. 78: 4366-4366. DOI: 10.1158/1538-7445.Am2018-4366  1
2018 Orzechowski C, Aithal A, Junker W, Kshirsagar P, Batra S, Jain M. Abstract 3829: Generation and characterization of novel antibodies against the β subunit of MUC4 Immunology. 78: 3829-3829. DOI: 10.1158/1538-7445.Am2018-3829  1
2018 Saxena S, Hayashi Y, Rachagani S, Batra SK, Singh RK. Abstract 3021: Plexin-B3 regulates cellular motility, invasiveness and metastasis in pancreatic cancer Cancer Research. 78: 3021-3021. DOI: 10.1158/1538-7445.Am2018-3021  1
2018 Chaudhary S, Pothuraju R, Atri P, Rachagani S, Batra SK, Macha MA. Abstract 1909: NR4A2 role in head and neck cancer: Mechanistic and functional analysis Cancer Research. 78: 1909-1909. DOI: 10.1158/1538-7445.Am2018-1909  1
2018 Siddiqui JA, Muniyan S, Seshacharyulu P, Rachagani S, Gupta S, Nasser MW, Datta K, Batra SK. Abstract 1091: Role of growth differentiation factor-15 in prostate cancer-bone environment: Understanding on bone metastasis Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1091  1
2018 Kanchan R, Perumal N, Atri P, Thapa I, Nasser M, Perry D, Batra S, Mahapatra S. PDTM-14. MiR-1253 IS A NOVEL TUMOR SUPPRESSOR GENE IN MEDULLOBLASTOMA Neuro-Oncology. 20: vi206-vi206. DOI: 10.1093/Neuonc/Noy148.856  0.01
2018 Perumal N, Kanchan R, Nasser M, Batra S, Mahapatra S. PDTM-08. ROLE OF miR-212 AS A TUMOR SUPPRESSOR GENE IN NON-SHH/WNT MEDULLOBLASTOMA Neuro-Oncology. 20: vi205-vi205. DOI: 10.1093/Neuonc/Noy148.850  0.01
2018 Kanchan R, Perumal NK, Naseer W, Perry D, Batra S, Mahapatra S. MBRS-59. MiR-1253, A CANDIDATE TUMOR SUPPRESSOR microRNA IN NON-SHH/WNT MEDULLOBLASTOMA Neuro-Oncology. 20: i141-i141. DOI: 10.1093/Neuonc/Noy059.503  0.01
2017 Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Emerging trends in the immunotherapy of pancreatic cancer. Cancer Letters. PMID 29242097 DOI: 10.1016/J.Canlet.2017.12.012  1
2017 Chen S, Boda SK, Batra SK, Li X, Xie J. Emerging Roles of Electrospun Nanofibers in Cancer Research. Advanced Healthcare Materials. PMID 29210522 DOI: 10.1002/Adhm.201701024  1
2017 Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Seminars in Cancer Biology. PMID 29199014 DOI: 10.1016/J.Semcancer.2017.11.020  1
2017 Nallasamy P, Chava S, Verma SS, Mishra S, Gorantla S, Coulter DW, Byrareddy SN, Batra SK, Gupta SC, Challagundla KB. PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective. Seminars in Cancer Biology. PMID 29196189 DOI: 10.1016/J.Semcancer.2017.11.009  1
2017 Burchett KM, Etekpo A, Batra SK, Yan Y, Ouellette MM. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Oncotarget. 8: 83754-83767. PMID 29137380 DOI: 10.18632/Oncotarget.19410  1
2017 Parte SC, Smolenkov AS, Batra SK, Ratajczak MZ, Kakar SS. Ovarian Cancer Stem Cells: Unravelling a Germline Connection. Stem Cells and Development. PMID 29078734 DOI: 10.1089/Scd.2017.0153  1
2017 Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K. Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy. Frontiers in Immunology. 8: 1228. PMID 29067024 DOI: 10.3389/Fimmu.2017.01228  1
2017 Ferdoush J, Karmakar S, Barman P, Kaja A, Uprety B, Batra SK, Bhaumik SR. Ubiquitin-proteasome system regulation of an evolutionarily conserved RNA polymerase II-associated factor 1 involved in pancreatic oncogenesis. Biochemistry. PMID 29023102 DOI: 10.1021/Acs.Biochem.7B00865  1
2017 Tan YC, Mirzapoiazova T, Won BM, Zhu L, Srivastava MK, Vokes EE, Husain AN, Batra SK, Sharma S, Salgia R. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL. Scientific Reports. 7: 9192. PMID 28835699 DOI: 10.1038/S41598-017-09078-4  1
2017 Ahmad R, Kumar B, Chen Z, Chen X, Müller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Oncogene. PMID 28783170 DOI: 10.1038/Onc.2017.259  1
2017 Burchett KM, Etekpo A, Batra SK, Yan Y, Ouellette MM. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Oncotarget. PMID 28753579 DOI: 10.18632/oncotarget.19410  1
2017 Yokoyama S, Higashi M, Tsutsumida H, Wakimoto J, Hamada T, Wiest E, Matsuo K, Kitazono I, Goto Y, Guo X, Hamada T, Yamada S, Hiraki T, Yonezawa S, Batra SK, et al. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer. Genes & Cancer. 8: 517-527. PMID 28680536 DOI: 10.18632/Genesandcancer.139  1
2017 Honjo K, Hiraki T, Higashi M, Noguchi H, Nomoto M, Yoshimura T, Batra SK, Yonezawa S, Semba I, Nakamura N, Tanimoto A, Yamada S. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase. Histology and Histopathology. 11913. PMID 28649694 DOI: 10.14670/Hh-11-913  1
2017 Quadros RM, Miura H, Harms DW, Akatsuka H, Sato T, Aida T, Redder R, Richardson GP, Inagaki Y, Sakai D, Buckley SM, Seshacharyulu P, Batra SK, Behlke MA, Zeiner SA, et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biology. 18: 92. PMID 28511701 DOI: 10.1186/S13059-017-1220-4  1
2017 Gautam SK, Kumar S, Cannon A, Hall B, Bhatia R, Nasser MW, Mahapatra S, Batra S, Jain M. MUC4 Mucin- A Therapeutic Target for Pancreatic Ductal Adenocarcinoma. Expert Opinion On Therapeutic Targets. PMID 28460571 DOI: 10.1080/14728222.2017.1323880  1
2017 Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, ... ... Batra SK, et al. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells. Oncotarget. 8: 20961-20973. PMID 28423495 DOI: 10.18632/Oncotarget.15468  1
2017 Seshacharyulu P, Baine MJ, Souchek JJ, Menning M, Kaur S, Yan Y, Ouellette MM, Jain M, Lin C, Batra SK. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica Et Biophysica Acta. PMID 28249796 DOI: 10.1016/J.Bbcan.2017.02.003  1
2017 Lakshmanan I, Salfity S, Seshacharyulu P, Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R, Lele SM, Ponnusamy MP, Batra SK, Ganti AK. MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28196872 DOI: 10.1158/1078-0432.Ccr-16-2530  1
2017 Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. Oncotarget. PMID 28122356 DOI: 10.18632/Oncotarget.14775  1
2017 Ahmad R, Sorrell MF, Batra SK, Dhawan P, Singh AB. Gut permeability and mucosal inflammation: bad, good or context dependent. Mucosal Immunology. PMID 28120842 DOI: 10.1038/Mi.2016.128  1
2017 Smolsky J, Kaur S, Hayashi C, Batra SK, Krasnoslobodtsev AV. Surface-Enhanced Raman Scattering-Based Immunoassay Technologies for Detection of Disease Biomarkers. Biosensors. 7. PMID 28085088 DOI: 10.3390/Bios7010007  1
2017 Das S, Batra S, Rachagani S. Mouse Model of Dextran Sodium Sulfate (DSS)-induced Colitis Bio-Protocol. 7. DOI: 10.21769/BIOPROTOC.2515  0.01
2017 Kshirsagar P, Rachagani S, Seshacharyulu P, Muniyan S, Mahato R, Batra SK, Jain M. Abstract LB-331: Advanced DNA-gold nanoprobe-based direct and sensitive quantification of novel microRNAs in prostate cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-331  1
2017 Hayashi C, Carmicheal J, Krasnoslobodtsev A, Haung Y, Brand RE, Batra SK, Kaur S. Abstract LB-244: Implication of secretory mucin MUC5AC and its glycan modification for detection of pancreatic cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-244  1
2017 Awaji M, Varney M, Purohit A, Batra SK, Singh RK. Abstract 942: CXCR2 acts as a checkpoint regulator of the pancreatic stellate cells activity within pancreatic cancer tumor microenvironment Cancer Research. 77: 942-942. DOI: 10.1158/1538-7445.Am2017-942  1
2017 Jahan R, Kaur S, Macha MA, Sheinin Y, Smith L, Meza J, Batra SK. Abstract 719: Pathobiological implications of Trefoil Factors in the progression and metastasis of pancreatic cancer Cancer Research. 77: 719-719. DOI: 10.1158/1538-7445.Am2017-719  1
2017 Chugh S, Rachagani S, Yu X, Neelamegham S, Xia L, Ouellette MM, Ponnusamy MP, Batra SK. Abstract 5801: Loss of core 1 β1,3-galactosyltransferase (C1GALT1) in pancreatic cancer leads to altered mucin glycosylation and increased tumor aggressiveness Cancer Research. 77: 5801-5801. DOI: 10.1158/1538-7445.Am2017-5801  1
2017 Saxena S, Purohit A, Batra SK, Singh RK. Abstract 5797: Semaphorin 5A preserves epithelial phenotype in pancreatic cancer cells by regulating cross-talk between Wnt and TGF-β signaling Cancer Research. 77: 5797-5797. DOI: 10.1158/1538-7445.Am2017-5797  1
2017 Hall B, Santhamma B, Cannon A, Bhatia R, Kumar S, Are C, Nair H, Nickisch K, Batra S. Abstract 5792: Development of cell line derived organoids to evaluate stroma targeted therapies in pancreatic cancer Cancer Research. 77: 5792-5792. DOI: 10.1158/1538-7445.Am2017-5792  1
2017 Yan Y, Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Batra SK. Abstract 5762: PR55-alpha associated PP2A promotes pancreatic tumorigenesis Cancer Research. 77: 5762-5762. DOI: 10.1158/1538-7445.Am2017-5762  1
2017 Cannon AC, Kumar S, Hall B, Bhatia R, Singh R, Batra S. Abstract 3912: Pancreatic cancer cell interaction with platelets impedes cell cycle progression and increases viability Cancer Research. 77: 3912-3912. DOI: 10.1158/1538-7445.Am2017-3912  1
2017 Carter K, Parte S, Batra SK, Ratajczak MZ, Kakar SS. Abstract 3895: Verrucarin J targets both cancer cells and cancer stem cells Cancer Research. 77: 3895-3895. DOI: 10.1158/1538-7445.Am2017-3895  1
2017 Banerjee K, Gautam S, Nasser WM, Kshirsagar P, Ross K, Spagnol G, Aithal A, Sorgen P, Batra SK, Kumar S, Narasimhan B, Jain M. Abstract 3678: Muc4 nanovaccine and checkpoint blockade based combination immunotherapy for pancreatic cancer Cancer Research. 77: 3678-3678. DOI: 10.1158/1538-7445.Am2017-3678  1
2017 Lakshmanan I, Rachagani S, Ponnusamy M, Chugh S, Dutta S, Muniyan S, Batra S, Kishore A. Abstract 2825: Gene expression profile in genetically engineered mouse model of lung cancer correlates with that in human lung adenocarcinoma Cancer Research. 77: 2825-2825. DOI: 10.1158/1538-7445.Am2017-2825  1
2017 Gupta S, Rachagani S, Kumar S, Batra SK, Jain M. Abstract 2691: Cigarette smoke induced upregulation of endothelin axis in the initiation of pancreatic cancer Immunology. 77: 2691-2691. DOI: 10.1158/1538-7445.Am2017-2691  1
2017 Ahmad R, kumar B, Chen Z, Chen S, Muller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB. Abstract 1342: Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy Cancer Research. 77: 1342-1342. DOI: 10.1158/1538-7445.Am2017-1342  1
2017 Vengoji R, Rachagani S, Gupta S, Mallya K, Jain M, Ponnusamy M, Batra S, Shonka N. Abstract 1104: Novel specific RTK targeting of EGFR/FAK axis in glioblastoma invasion Cancer Research. 77: 1104-1104. DOI: 10.1158/1538-7445.Am2017-1104  1
2016 Parekh R, Krol G, Piraka C, Batra S. A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Biliary Duct in a Patient with Prostate Adenocarcinoma. Case Reports in Gastroenterology. 10: 743-748. PMID 28100995 DOI: 10.1159/000450539  0.01
2016 Kumar S, Batra SK. Interlukin-22 Connects Smoking and Pancreatic Fibrosis During Chronic Pancreatitis. Gastroenterology. PMID 27983953 DOI: 10.1053/J.Gastro.2016.10.033  1
2016 Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, ... ... Batra SK, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. The American Journal of Gastroenterology. PMID 27845339 DOI: 10.1038/Ajg.2016.482  1
2016 Kumar S, Cruz E, Joshi S, Patel A, Jahan R, Batra SK, Jain M. Genetic Variants of Mucins: Unexplored Conundrum. Carcinogenesis. PMID 27838635 DOI: 10.1093/Carcin/Bgw120  1
2016 Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance. Oncotarget. PMID 27705923 DOI: 10.18632/Oncotarget.12347  1
2016 Ingersoll MA, Miller DR, Martinez O, Wakefield CB, Hsieh KC, Simha MV, Kao CL, Chen HT, Batra SK, Lin MF. Statin Derivatives as Therapeutic Agents for Castration-Resistant Prostate Cancer. Cancer Letters. PMID 27687622 DOI: 10.1016/J.Canlet.2016.09.008  1
2016 Hiraki T, Yamada S, Higashi M, Hatanaka K, Yokoyama S, Kitazono I, Goto Y, Kirishima M, Batra SK, Yonezawa S, Tanimoto A. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival. Histology and Histopathology. 11824. PMID 27672051 DOI: 10.14670/Hh-11-824  1
2016 Pai P, Rachagani S, Dhawan P, Sheinin YM, Macha MA, Qazi AK, Chugh S, Ponnusamy MP, Mallya K, Pothuraju R, Batra SK. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer. Genes & Cancer. 7: 154-68. PMID 27551331 DOI: 10.18632/Genesandcancer.108  1
2016 Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes & Cancer. 7: 110-24. PMID 27382435 DOI: 10.18632/Genesandcancer.104  1
2016 Yokoyama S, Higashi M, Kitamoto S, Oeldorf M, Knippschild U, Kornmann M, Maemura K, Kurahara H, Wiest E, Hamada T, Kitazono I, Goto Y, Tasaki T, Hiraki T, Hatanaka K, ... Batra SK, et al. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Oncotarget. PMID 27283771 DOI: 10.18632/Oncotarget.9924  1
2016 Wang Y, Kumar S, Rachagani S, Sajja BR, Xie Y, Hang Y, Jain M, Li J, Boska MD, Batra SK, Oupický D. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials. 101: 108-120. PMID 27267632 DOI: 10.1016/J.Biomaterials.2016.05.042  1
2016 Suklabaidya S, Das B, Ali SA, Jain S, Swaminathan S, Mohanty AK, Panda SK, Dash P, Chakraborty S, Batra SK, Senapati S. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget. PMID 27259232 DOI: 10.18632/Oncotarget.9729  1
2016 Chugh S, Meza J, Sheinin YM, Ponnusamy MP, Batra SK. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. British Journal of Cancer. PMID 27187683 DOI: 10.1038/Bjc.2016.116  1
2016 Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Molecular Oncology. PMID 27185392 DOI: 10.1016/J.Molonc.2016.04.007  1
2016 Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. PMID 27181206 DOI: 10.1038/Onc.2016.163  1
2016 Joshi S, Kumar S, Ponnusamy MP, Batra SK. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. Oncogene. PMID 27109098 DOI: 10.1038/Onc.2016.119  1
2016 Dutta S, Roy S, Polavaram NS, Baretton GB, Muders MH, Batra S, Datta K. NRP2 transcriptionally regulates its downstream effector WDFY1. Scientific Reports. 6: 23588. PMID 27026195 DOI: 10.1038/Srep23588  1
2016 Kanteti R, Batra SK, Lennon FE, Salgia R. FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. PMID 26980710 DOI: 10.18632/Oncotarget.8040  1
2016 Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WL, Manne U, Batra SK. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. Cancer Letters. PMID 26898938 DOI: 10.1016/J.Canlet.2016.02.016  1
2016 Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y. PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling. Cancer Research. PMID 26893480 DOI: 10.1158/0008-5472.Can-15-2119  1
2016 Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget. PMID 26840089 DOI: 10.18632/Oncotarget.7103  1
2016 Purohit A, Varney M, Rachagani S, Ouellette MM, Batra SK, Singh RK. CXCR2 signaling regulates KRAS (G12D)-induced autocrine growth of pancreatic cancer. Oncotarget. PMID 26771140 DOI: 10.18632/Oncotarget.6906  1
2016 Pai P, Rachagani S, Dhawan P, Batra SK. Mucins and Wnt/β-catenin Signaling in Gastrointestinal Cancers: An Unholy Nexus. Carcinogenesis. PMID 26762229 DOI: 10.1093/Carcin/Bgw005  1
2016 Lakshmanan I, Rachagani S, Hauke R, Krishn SR, Paknikar S, Seshacharyulu P, Karmakar S, Nimmakayala RK, Kaushik G, Johansson SL, Carey GB, Ponnusamy MP, Kaur S, Batra SK, Ganti AK. MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling. Oncogene. PMID 26751774 DOI: 10.1038/Onc.2015.478  1
2016 Patel A, Kaur S, Smith L, Are C, Batra S. Diagnostic potential of mucins in pancreatic juice for pancreatic cancer. Journal of Clinical Oncology. 34: 222-222. DOI: 10.1200/Jco.2016.34.4_Suppl.222  0.01
2016 Shehan J, Gupta S, Rachagani S, Zhang Y, Mallya K, Pai P, Kaur S, Jain M, Kueh A, White M, Aizenberg M, McComb R, Smith L, Batra S, Shonka NA. Biomarkers for glioblastoma: MMP2 and NGAL. Journal of Clinical Oncology. 34: e13516-e13516. DOI: 10.1200/Jco.2016.34.15_Suppl.E13516  0.01
2016 Ingersoll MA, Muniyan S, Lin F, Yuan T, Chou Y, Batra SK, Lin M. Abstract 5069: p66Shc regulates the migration of castration-resistant prostate cancer Cancer Research. 76: 5069-5069. DOI: 10.1158/1538-7445.Am2016-5069  1
2016 Cruz E, Batra SK. Abstract 4555: Identification of bone morphogenetic protein 2 splice variant in pancreatic cancer reveals cross-talk between endocytic and autophagy pathways Cancer Research. 76: 4555-4555. DOI: 10.1158/1538-7445.Am2016-4555  1
2016 Gupta S, Rachagani S, Kumar S, Mallya K, Batra SK, Jain M. Abstract 4191: Alterations in endothelin axis during pancreatic acinar to ductal metaplasia Cancer Research. 76: 4191-4191. DOI: 10.1158/1538-7445.Am2016-4191  1
2016 Dutta S, Roy S, Polavaram NS, Stanton M, Batra S, Muders MH, Datta K. Abstract 3526: Novel function of NRP2 in therapy resistant metastatic cancer Cancer Research. 76: 3526-3526. DOI: 10.1158/1538-7445.Am2016-3526  1
2016 Aithal A, Junker W, Kaur S, Das S, Kshirsagar P, Rachagani S, Mallya K, Jain M, Batra SK. Abstract 2978: Characterization of novel antibodies for understanding MUC16 cleavage and its pathological implications in cancer Cancer Research. 76: 2978-2978. DOI: 10.1158/1538-7445.Am2016-2978  1
2016 Karmakar S, Seshacharyulu P, Vaz AP, Lakshmanan I, Ponnusamy MP, Batra SK. Abstract 2495: hPaf1/PD2 interacts with OCT3/4 in maintenance of the self-renewal process of ovarian cancer stem cells Cancer Research. 76: 2495-2495. DOI: 10.1158/1538-7445.Am2016-2495  1
2016 Nimmakayala R, Seshacharyulu P, Chugh S, Lakshmanan I, Rachagani S, Batra SK, MPP. Abstract 2490: Smoking enriches cancer stem cell population and activates Sox9 through NF-kB signaling in pancreatic ductal adenocarcinoma Cancer Research. 76: 2490-2490. DOI: 10.1158/1538-7445.Am2016-2490  1
2016 Kaushik G, Seshacharyulu P, Rachagani S, Macha MA, Ponnusamy MP, Batra SK. Abstract 1726: Targeting pancreatic cancer stem cells by afatinib in organoid culture Cancer Research. 76: 1726-1726. DOI: 10.1158/1538-7445.Am2016-1726  1
2016 Saxena S, Purohit A, Varney M, Batra SK, Singh RK. Abstract 1683: Dual role of semaphorin5A in maintaining epithelial and mesenchymal phenotype in metastatic pancreatic cancer Cancer Research. 76: 1683-1683. DOI: 10.1158/1538-7445.Am2016-1683  1
2016 Ouellette MM, Batra SK, Yan Y. Abstract 1669: Inhibition of the Rac1/PAK pathway sensitizes pancreatic cancer cells to gamma-irradiation Cancer Research. 76: 1669-1669. DOI: 10.1158/1538-7445.Am2016-1669  1
2016 Muniyan S, Haridas D, Rachagani S, Lakshmanan I, Gupta S, Chugh S, Seshacharyulu P, Ponnusamy MP, Batra SK. Abstract 1629: Novel interaction of MUC16 with FAK activate EMT process and metastasis of pancreatic ductal adenocarcinoma Cancer Research. 76: 1629-1629. DOI: 10.1158/1538-7445.Am2016-1629  1
2015 Krishn SR, Batra SK, Kaur S. Advances in miRNA-Mediated Mucin Regulation. Current Pharmacology Reports. 1: 355-364. PMID 27867838 DOI: 10.1007/S40495-014-0010-X  1
2015 Das A, Durrant D, Mitchell C, Dent P, Batra SK, Kukreja RC. Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95. Oncotarget. PMID 26716643 DOI: 10.18632/Oncotarget.6749  1
2015 Vaz AP, Deb S, Rachagani S, Dey P, Muniyan S, Lakshmanan I, Karmakar S, Smith L, Johansson S, Lele S, Ouellette M, Ponnusamy MP, Batra SK. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Oncotarget. PMID 26689992 DOI: 10.18632/Oncotarget.6580  1
2015 Kaur S, Krishn SR, Rachagani S, Batra SK. Significance of microRNA-based biomarkers for pancreatic cancer. Annals of Translational Medicine. 3: 277. PMID 26605323 DOI: 10.3978/J.Issn.2305-5839.2015.10.32  1
2015 Dutta S, Roy S, Polavaram NS, Stanton MJ, Zhang H, Bhola T, Hönscheid P, Donohue TM, Band H, Batra SK, Muders MH, Datta K. Neuropilin-2 regulates endosome maturation and EGFR trafficking to support cancer cell pathobiology. Cancer Research. PMID 26560516 DOI: 10.1158/0008-5472.Can-15-1488  1
2015 Das S, Batra SK. Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy. Cancer Research. PMID 26527287 DOI: 10.1158/0008-5472.Can-15-1050  1
2015 Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Molecular Oncology. PMID 26526617 DOI: 10.1016/J.Molonc.2015.10.005  1
2015 Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... Batra SK, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/Nature15756  1
2015 Rachagani S, Macha MA, Menning MS, Dey P, Pai P, Smith LM, Mo YY, Batra SK. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget. PMID 26516699 DOI: 10.18632/Oncotarget.5641  1
2015 Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Oncogene. PMID 26364605 DOI: 10.1038/Onc.2015.327  1
2015 Chugh S, Gnanapragassam VS, Jain M, Rachagani S, Ponnusamy MP, Batra SK. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets. Biochimica Et Biophysica Acta. 1856: 211-225. PMID 26318196 DOI: 10.1016/J.Bbcan.2015.08.003  1
2015 Muniyan S, Chen SJ, Lin FF, Wang Z, Mehta PP, Batra SK, Lin MF. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cellular Signalling. PMID 26257301 DOI: 10.1016/J.Cellsig.2015.08.002  1
2015 Ingersoll MA, Lyons AS, Muniyan S, D'Cunha N, Robinson T, Hoelting K, Dwyer JG, Bu XR, Batra SK, Lin MF. Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells. Plos One. 10: e0131811. PMID 26121643 DOI: 10.1371/Journal.Pone.0131811  1
2015 Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. PMID 26046375 DOI: 10.18632/Oncotarget.4078  1
2015 Das S, Majhi PD, Al-Mugotir MH, Rachagani S, Sorgen P, Batra SK. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments. Scientific Reports. 5: 9759. PMID 26044153 DOI: 10.1038/Srep09759  1
2015 Lakshmanan I, Seshacharyulu P, Haridas D, Rachagani S, Gupta S, Joshi S, Guda C, Yan Y, Jain M, Ganti AK, Ponnusamy MP, Batra SK. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Oncotarget. PMID 26035354 DOI: 10.18632/Oncotarget.3912  1
2015 Macha MA, Rachagani S, Pai P, Gupta S, Lydiatt WM, Smith RB, Johansson SL, Lele SM, Kakar SS, Farghaly H, Lee JH, Meza J, Ganti AK, Jain M, Batra SK. MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway. Oncogene. 34: 2814. PMID 25994150 DOI: 10.1038/Onc.2015.116  1
2015 Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... Batra SK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169  1
2015 Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, et al. Early Detection of Sporadic Pancreatic Cancer: Summative Review. Pancreas. 44: 693-712. PMID 25931254 DOI: 10.1097/Mpa.0000000000000368  1
2015 Higashi M, Yokoyama S, Yamamoto T, Goto Y, Kitazono I, Hiraki T, Taguchi H, Hashimoto S, Fukukura Y, Koriyama C, Mataki Y, Maemura K, Shinchi H, Jain M, Batra SK, et al. Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma. Pancreas. 44: 728-34. PMID 25906442 DOI: 10.1097/Mpa.0000000000000362  1
2015 Jain S, Suklabaidya S, Das B, Raghav SK, Batra SK, Senapati S. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells. The Prostate. 75: 1020-33. PMID 25833062 DOI: 10.1002/Pros.22983  1
2015 Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget. 6: 5772-87. PMID 25691062 DOI: 10.18632/Oncotarget.3308  1
2015 Seshacharyulu P, Ponnusamy MP, Rachagani S, Lakshmanan I, Haridas D, Yan Y, Ganti AK, Batra SK. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. Oncotarget. 6: 5164-81. PMID 25686822 DOI: 10.18632/Oncotarget.3286  1
2015 Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK. Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer. Oncotarget. 6: 3887-903. PMID 25682877 DOI: 10.18632/Oncotarget.2932  1
2015 Kumar V, Mondal G, Slavik P, Rachagani S, Batra SK, Mahato RI. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Molecular Pharmaceutics. 12: 1289-98. PMID 25679326 DOI: 10.1021/Mp500847S  1
2015 Joshi S, Kumar S, Bafna S, Rachagani S, Wagner KU, Jain M, Batra SK. Genetically engineered mucin mouse models for inflammation and cancer. Cancer Metastasis Reviews. PMID 25634251 DOI: 10.1007/S10555-015-9549-1  1
2015 Macha MA, Krishn SR, Jahan R, Banerjee K, Batra SK, Jain M. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. Cancer Treatment Reviews. 41: 277-88. PMID 25624117 DOI: 10.1016/J.Ctrv.2015.01.001  1
2015 Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, ... Batra SK, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918 DOI: 10.18632/Oncotarget.2990  1
2015 Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed? Current Pharmaceutical Design. 21: 1249-55. PMID 25506899 DOI: 10.2174/1381612821666141211115234  1
2015 Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Advanced Drug Delivery Reviews. 81: 16-33. PMID 25453266 DOI: 10.1016/J.Addr.2014.10.020  1
2015 Lakshmanan I, Ponnusamy MP, Macha MA, Haridas D, Majhi PD, Kaur S, Jain M, Batra SK, Ganti AK. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 19-27. PMID 25319180 DOI: 10.1097/Jto.0000000000000404  1
2015 Krasnoslobodtsev AV, Torres MP, Kaur S, Vlassiouk IV, Lipert RJ, Jain M, Batra SK, Lyubchenko YL. Nano-immunoassay with improved performance for detection of cancer biomarkers. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 167-73. PMID 25200613 DOI: 10.1016/J.Nano.2014.08.012  1
2015 Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, Higashi M, Yonezawa S, Sugihara K. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. International Journal of Clinical Oncology. 20: 298-307. PMID 24909613 DOI: 10.1007/S10147-014-0710-6  1
2015 Yan Y, Hein AL, Greer PM, Wang Z, Kolb RH, Batra SK, Cowan KH. A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation. Oncogene. 34: 2215-26. PMID 24909175 DOI: 10.1038/Onc.2014.167  1
2015 Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 34: 2052-60. PMID 24909166 DOI: 10.1038/Onc.2014.154  1
2015 Macha MA, Rachagani S, Pai P, Gupta S, Lydiatt WM, Smith RB, Johansson SL, Lele SM, Kakar SS, Farghaly H, Lee JH, Meza J, Ganti AK, Jain M, Batra SK. MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway. Oncogene. 34: 1698-708. PMID 24747969 DOI: 10.1038/Onc.2014.102  1
2015 Parekh R, Krol G, Piraka C, Yoshida A, Batra SK. A Rare Case of Intraductal Papillary Mucinous Neoplasm of Biliary Duct in a Patient With Prostate Adenocarcinoma American Journal of Gastroenterology. 110: S78-S79. DOI: 10.14309/00000434-201510001-00183  0.01
2015 Chugh S, Gnanapragassam VS, Jain M, Ponnusamy M, Batra SK. Abstract 4983: GALNT3 mediated differential MUC4 glycosylation in the progression of pancreatic cancer Cancer Research. 75: 4983-4983. DOI: 10.1158/1538-7445.Am2015-4983  1
2015 Purohit A, Varney M, Rachagani S, Myneni P, Ouellette M, Batra SK, Singh RK. Abstract 3178: Targeting CXCR2 signaling inhibitsKRAS(G12D)induced autocrine growth transformation by suppressing ERK activation in pancreatic cancer Cancer Research. 75: 3178-3178. DOI: 10.1158/1538-7445.Am2015-3178  1
2015 Joshi S, Kumar S, Ponnusamy MP, Batra SK. Abstract 1256: MUC4 is negatively regulated by hypoxia in ROS-dependent manner in pancreatic cancer Cancer Research. 75: 1256-1256. DOI: 10.1158/1538-7445.Am2015-1256  1
2015 Senapati S, Singh RK, Batra SK. Tumor microenvironment: Blood vascular system in cancer metastasis Systems Biology of Cancer. 309-322. DOI: 10.1017/9780511979811.021  1
2015 Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer Advanced Drug Delivery Reviews. 81: 16-33. DOI: 10.1016/j.addr.2014.10.020  1
2015 Das S, Batra SK. Pancreatic cancer metastasis: Are we being pre-EMTed? Current Pharmaceutical Design. 21: 1249-1255.  1
2014 Vaz AP, Ponnusamy MP, Seshacharyulu P, Batra SK. A concise review on the current understanding of pancreatic cancer stem cells. Journal of Cancer Stem Cell Research. 2. PMID 26451384  1
2014 Shibahara H, Higashi M, Yokoyama S, Rousseau K, Kitazono I, Osako M, Shirahama H, Tashiro Y, Kurumiya Y, Narita M, Kuze S, Hasagawa H, Kato T, Kubota H, Suzuki H, ... Batra SK, et al. A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor. Plos One. 9: e115613. PMID 25551773 DOI: 10.1371/Journal.Pone.0115613  1
2014 Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson SL, Ponnusamy MP, Jain M, Batra SK. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. PMID 25531332 DOI: 10.1038/Onc.2014.409  1
2014 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, St Lawrence E, Gagneux P, Kaur S, Sharma P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. World Journal of Gastroenterology : Wjg. 20: 14913-20. PMID 25356051 DOI: 10.3748/Wjg.V20.I40.14913  1
2014 Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Oncotarget. 5: 10251-70. PMID 25344910 DOI: 10.18632/Oncotarget.2500  1
2014 Ponnusamy MP, Batra SK. Insights into the role of nicotine in pancreatic stem cell activation and acinar dedifferentiation. Gastroenterology. 147: 962-5. PMID 25265575 DOI: 10.1053/J.Gastro.2014.09.026  1
2014 Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. Plos One. 9: e107596. PMID 25264898 DOI: 10.1371/Journal.Pone.0107596  1
2014 Joshi S, Kumar S, Choudhury A, Ponnusamy MP, Batra SK. Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget. 5: 7272-84. PMID 25261375 DOI: 10.18632/Oncotarget.2370  1
2014 Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. British Journal of Cancer. 111: 1139-49. PMID 25025965 DOI: 10.1038/Bjc.2014.385  1
2014 Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Ganti AK, Batra SK. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells British Journal of Cancer. 111: 486-496. PMID 25003666 DOI: 10.1038/Bjc.2014.152  1
2014 Haridas D, Ponnusamy MP, Chugh S, Lakshmanan I, Seshacharyulu P, Batra SK. MUC16: Molecular analysis and its functional implications in benign and malignant conditions Faseb Journal. 28: 4183-4199. PMID 25002120 DOI: 10.1096/Fj.14-257352  1
2014 Chakraborty S, Smith L, Ganti AK, Bonthu N, Batra SK. Author's response to "Country of origin and breast cancer survival". Asia-Pacific Journal of Clinical Oncology. 10: 280. PMID 24965198 DOI: 10.1111/Ajco.12212  1
2014 Dey P, Rachagani S, Vaz AP, Ponnusamy MP, Batra SK. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget. 5: 4480-91. PMID 24947474 DOI: 10.18632/Oncotarget.2041  1
2014 Muniyan S, Ingersoll MA, Batra SK, Lin MF. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochimica Et Biophysica Acta. 1846: 88-98. PMID 24747769 DOI: 10.1016/J.Bbcan.2014.04.006  1
2014 Shibahara H, Higashi M, Koriyama C, Yokoyama S, Kitazono I, Kurumiya Y, Narita M, Kuze S, Kyokane T, Mita S, Arai T, Kato T, Yuasa N, Yamaguchi R, Kubota H, ... Batra SK, et al. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. Plos One. 9: e86111. PMID 24722639 DOI: 10.1371/Journal.Pone.0086111  1
2014 Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, Yamaguchi T, Arisaka Y, Niihara T, Nishimata H, Tanaka S, Takaori K, Batra SK, Yonezawa S. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. Plos One. 9: e93760. PMID 24714692 DOI: 10.1371/Journal.Pone.0093760  1
2014 Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. Plos One. 9: e92742. PMID 24671186 DOI: 10.1371/Journal.Pone.0092742  1
2014 Gupta S, Batra S, Jain M. Antibody labeling with radioiodine and radiometals. Methods in Molecular Biology (Clifton, N.J.). 1141: 147-57. PMID 24567137 DOI: 10.1007/978-1-4939-0363-4_9  1
2014 Macha MA, Seshacharyulu P, Krishn SR, Pai P, Rachagani S, Jain M, Batra SK. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers. Current Pharmaceutical Design. 20: 5287-97. PMID 24479799 DOI: 10.2174/1381612820666140128213117  1
2014 Mimeault M, Batra SK. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Cancer Epidemiology Biomarkers and Prevention. 23: 234-254. PMID 24273063 DOI: 10.1158/1055-9965.Epi-13-0785  1
2014 Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 688-700. PMID 24240113 DOI: 10.1158/1078-0432.Ccr-13-2174  1
2014 Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends in Molecular Medicine. 20: 36-47. PMID 24238736 DOI: 10.1016/J.Molmed.2013.10.005  1
2014 Mimeault M, Batra SK. Introduction at the special issue on implications of cancer stem/progenitor cell concepts in molecular oncology and novel targeted therapies. Molecular Aspects of Medicine. 39: 1-2. PMID 24080440 DOI: 10.1016/J.Mam.2013.09.001  1
2014 Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine. 39: 3-32. PMID 23994756 DOI: 10.1016/J.Mam.2013.08.001  1
2014 Chakraborty S, Smith L, Ganti AK, Bonthu N, Shimizhu T, Batra SK. Breast cancer survival of Hispanic women in the USA is influenced by country of origin. Asia-Pacific Journal of Clinical Oncology. 10: 124-32. PMID 23551959 DOI: 10.1111/Ajco.12063  1
2014 Purohit A, Varney M, Rachagani S, Ouellette M, Batra SK, Singh RK. Abstract 4874: CXCR2 signaling axis- a helping hand to KRAS(G12D) mutation in pancreatic cancer initiation Cancer Research. 74: 4874-4874. DOI: 10.1158/1538-7445.Am2014-4874  1
2013 Lakshmanan I, Batra SK. Protocol for Apoptosis Assay by Flow Cytometry Using Annexin V Staining Method. Bio-Protocol. 3. PMID 27430005  1
2013 Torres MP, Rachagani S, Souchek JJ, Mallya K, Johansson SL, Batra SK. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. Plos One. 8: e80580. PMID 24278292 DOI: 10.1371/Journal.Pone.0080580  1
2013 Radhakrishnan P, Mohr AM, Grandgenett PM, Steele MM, Batra SK, Hollingsworth MA. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. Plos One. 8: e73356. PMID 24204560 DOI: 10.1371/Journal.Pone.0073356  1
2013 Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK. Emerging role of mucins in epithelial to mesenchymal transition. Current Cancer Drug Targets. 13: 945-56. PMID 24168188 DOI: 10.2174/15680096113136660100  1
2013 Vaz AP, Ponnusamy MP, Batra SK. Cancer stem cells and therapeutic targets: an emerging field for cancer treatment. Drug Delivery and Translational Research. 3: 113-20. PMID 24077517 DOI: 10.1007/S13346-012-0095-X  1
2013 Macha MA, Batra SK, Ganti AK. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. Cancer Management and Research. 5: 197-203. PMID 23940421 DOI: 10.2147/Cmar.S45976  1
2013 Kitazono I, Higashi M, Kitamoto S, Yokoyama S, Horinouchi M, Osako M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 42: 1120-8. PMID 23921963 DOI: 10.1097/Mpa.0B013E3182965915  1
2013 Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK, Jain M. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Letters. 341: 166-77. PMID 23920124 DOI: 10.1016/J.Canlet.2013.07.037  1
2013 Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology. 10: 607-20. PMID 23856888 DOI: 10.1038/Nrgastro.2013.120  1
2013 Jain M, Gupta S, Kaur S, Ponnusamy MP, Batra SK. Emerging trends for radioimmunotherapy in solid tumors. Cancer Biotherapy & Radiopharmaceuticals. 28: 639-50. PMID 23844555 DOI: 10.1089/Cbr.2013.1523  1
2013 Pai P, Rachagani S, Are C, Batra SK. Prospects of miRNA-based therapy for pancreatic cancer. Current Drug Targets. 14: 1101-9. PMID 23834151 DOI: 10.2174/13894501113149990181  1
2013 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, Lawrence ES, Gagneux P, Batra SK, Ho SB. Erratum: Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers (Digestive Diseases and Sciences (2012) 57 (2535-2544) DOI: 10.1007/s10620-012-2205-5) Digestive Diseases and Sciences. 58. PMID 23712373 DOI: 10.1007/S10620-013-2723-9  1
2013 Pandey P, Seshacharyulu P, Das S, Rachagani S, Ponnusamy MP, Yan Y, Johansson SL, Datta K, Fong Lin M, Batra SK. Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway. British Journal of Cancer. 108: 2590-600. PMID 23598299 DOI: 10.1038/Bjc.2013.160  1
2013 Horn A, Chakraborty S, Dey P, Haridas D, Souchek J, Batra SK, Lele SM. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Archives of Pathology & Laboratory Medicine. 137: 546-51. PMID 23544943 DOI: 10.5858/Arpa.2011-0229-Oa  1
2013 Mimeault M, Batra SK. Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World Journal of Clinical Oncology. 4: 4-13. PMID 23539141 DOI: 10.5306/Wjco.V4.I1.4  1
2013 Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Letters. 336: 270-80. PMID 23523869 DOI: 10.1016/J.Canlet.2013.03.017  1
2013 Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP, Hebrok M, Witkiewicz AK, Brody JR, et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30. PMID 23467612 DOI: 10.1158/0008-5472.Can-12-2067  1
2013 Seshacharyulu P, Pandey P, Datta K, Batra SK. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Letters. 335: 9-18. PMID 23454242 DOI: 10.1016/J.Canlet.2013.02.036  1
2013 Mimeault M, Johansson SL, Batra SK. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. British Journal of Cancer. 108: 1079-91. PMID 23449353 DOI: 10.1038/Bjc.2012.484  1
2013 Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P, Smith LM, Lele SM, Batra SK. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. Plos One. 8: e54455. PMID 23408941 DOI: 10.1371/Journal.Pone.0054455  1
2013 Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Plos One. 8: e55171. PMID 23383312 DOI: 10.1371/Journal.Pone.0055171  1
2013 Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 398-407. PMID 23370366 DOI: 10.1097/Jto.0B013E3182829E06  1
2013 Gnanapragassam VS, Jain M, Batra SK. Analysis of tumor-associated mucin glycotopes by Western transfer methods. Methods in Molecular Biology (Clifton, N.J.). 980: 331-40. PMID 23359164 DOI: 10.1007/978-1-62703-287-2_19  1
2013 Baine MJ, Mallya K, Batra SK. Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients. Methods in Molecular Biology (Clifton, N.J.). 980: 157-73. PMID 23359153 DOI: 10.1007/978-1-62703-287-2_8  1
2013 Kaur S, Shimizu T, Baine MJ, Kumar S, Batra SK. Immunohistochemistry of pancreatic neoplasia. Methods in Molecular Biology (Clifton, N.J.). 980: 29-42. PMID 23359148 DOI: 10.1007/978-1-62703-287-2_3  1
2013 Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. Journal of Cellular and Molecular Medicine. 17: 30-54. PMID 23301832 DOI: 10.1111/Jcmm.12004  1
2013 Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, ... Batra SK, et al. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas. Pancreas. 42: 494-501. PMID 23146921 DOI: 10.1097/Mpa.0B013E31826A8597  1
2013 Mimeault M, Batra SK. Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials. Drug Discovery Today. 18: 128-40. PMID 22903142 DOI: 10.1016/J.Drudis.2012.08.002  1
2013 Momi N, Ponnusamy MP, Kaur S, Rachagani S, Kunigal SS, Chellappan S, Ouellette MM, Batra SK. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 32: 1384-95. PMID 22614008 DOI: 10.1038/Onc.2012.163  1
2013 Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. American Journal of Clinical Oncology. 36: 132-42. PMID 22441339 DOI: 10.1097/Coc.0B013E3182438Ddf  1
2013 Das S, Torres-Gonzalez MP, Majhi PD, Lakshmanan I, Ponnusamy MP, Rachagani S, Cruz E, Haridas D, Batra SK. Abstract 5113: Carboxyl terminal region of MUC16 is critical for tumor cell invasion and drug resistance. Cancer Research. 73: 5113-5113. DOI: 10.1158/1538-7445.Am2013-5113  1
2013 Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Batra S. Abstract 271: Overexpression of hPaf1/PD2 in pancreatic cancer stem cells results in stemness and drug resistance: a novel target for pancreatic cancer therapy. Cancer Research. 73: 271-271. DOI: 10.1158/1538-7445.Am2013-271  1
2013 Lakshmanan I, Majhi PD, Ponnusamy MP, Das S, Seshacharyulu P, Haridas D, Batra SK, Ganti A. Abstract 1760: MUC16 upregulates TSPYL5 gene and mediates Lung cancer cell proliferation by suppressing p53 activity. Cancer Research. 73: 1760-1760. DOI: 10.1158/1538-7445.Am2013-1760  1
2013 Haridas D, Lakshmanan I, Ponnusamy MP, Rachagani S, Das S, Kumar S, Batra SK. Abstract 1745: Role and mechanism of MUC16 in the pathogenesis of pancreatic cancer. Cancer Research. 73: 1745-1745. DOI: 10.1158/1538-7445.Am2013-1745  1
2013 Purohit A, Varney M, Rachagani S, Ouellete M, Batra SK, Singh RK. Abstract 1431: Upregulation of CXCR2 and its ligands in KRAS oncogene-induced initiation of pancreatic cancer. Cancer Research. 73: 1431-1431. DOI: 10.1158/1538-7445.Am2013-1431  1
2013 Souchek J, Chakraborty S, Rachagani S, Hauke R, Batra S. Glucocorticoids augment resistance to gemcitabine in pancreatic cancer cells Pancreatology. 13: e75. DOI: 10.1016/J.Pan.2012.12.316  0.01
2013 Seshacharyulu P, Ponnusamy M, Lakshmanan I, Batra S. Pan-ErbB inhibitor CI 1033 on pancreatic cancer therapy Pancreatology. 13: e72-e73. DOI: 10.1016/J.Pan.2012.12.308  0.01
2013 Kaur S, Bafna S, Rachagani S, Ganti A, Batra S. Mucin MUC4 resists gemcitabine-induced pancreatic cancer cell death by promoting autophagy Pancreatology. 13: e43. DOI: 10.1016/J.Pan.2012.12.204  0.01
2013 Joshi S, Kumar S, Batra S. MUC4 is a novel regulator of EGFR trafficking in pancreatic cancer Pancreatology. 13: e41. DOI: 10.1016/J.Pan.2012.12.197  0.01
2012 Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterologica E Dietologica. 58: 283-97. PMID 23207606  1
2012 Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. Plos One. 7: e49251. PMID 23152882 DOI: 10.1371/Journal.Pone.0049251  1
2012 Rachagani S, Torres MP, Kumar S, Haridas D, Baine M, Macha MA, Kaur S, Ponnusamy MP, Dey P, Seshacharyulu P, Johansson SL, Jain M, Wagner KU, Batra SK. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Journal of Hematology & Oncology. 5: 68. PMID 23102107 DOI: 10.1186/1756-8722-5-68  1
2012 Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in Medicine. 6: 597-612. PMID 23075238 DOI: 10.2217/Bmm.12.69  1
2012 Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB, Anderson JM, Lele S, Hollingsworth MA, Band V, Batra SK. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6188-98. PMID 22977192 DOI: 10.1158/1078-0432.Ccr-12-1789  1
2012 Kitamoto S, Yokoyama S, Higashi M, Yamada N, Matsubara S, Takao S, Batra SK, Yonezawa S. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer. Plos One. 7: e44108. PMID 22970168 DOI: 10.1371/Journal.Pone.0044108  1
2012 Rachagani S, Macha MA, Ponnusamy MP, Haridas D, Kaur S, Jain M, Batra SK. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis. 33: 1953-64. PMID 22791819 DOI: 10.1093/Carcin/Bgs225  1
2012 Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang CS, Ashour AE, Batra SK, Singh RK. Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation. British Journal of Cancer. 107: 501-7. PMID 22782341 DOI: 10.1038/Bjc.2012.298  0.01
2012 Chen AC, Migliaccio I, Rimawi M, Lopez-Tarruella S, Creighton CJ, Massarweh S, Huang C, Wang YC, Batra SK, Gutierrez MC, Osborne CK, Schiff R. Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies. Breast Cancer Research and Treatment. 134: 583-93. PMID 22644656 DOI: 10.1007/S10549-012-2082-9  1
2012 Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. Carcinogenesis. 33: 1617-28. PMID 22623649 DOI: 10.1093/Carcin/Bgs186  1
2012 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Manugian V, St Lawrence E, Gagneux P, Batra SK, Ho SB. Membrane-bound mucins and mucin terminal glycans expression in idiopathic or Helicobacter pylori, NSAID associated peptic ulcers. Digestive Diseases and Sciences. 57: 2535-44. PMID 22576713 DOI: 10.1007/S10620-012-2205-5  1
2012 Kunigal S, Ponnusamy MP, Momi N, Batra SK, Chellappan SP. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Molecular Cancer. 11: 24. PMID 22537161 DOI: 10.1186/1476-4598-11-24  1
2012 Kelsey L, Katoch P, Johnson KE, Batra SK, Mehta PP. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Plos One. 7: e32846. PMID 22514600 DOI: 10.1371/Journal.Pone.0032846  1
2012 Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica Et Biophysica Acta. 1826: 129-69. PMID 22513004 DOI: 10.1016/J.Bbcan.2012.03.008  1
2012 Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Letters. 323: 29-40. PMID 22475682 DOI: 10.1016/J.Canlet.2012.03.031  1
2012 Mimeault M, Batra SK. Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies. Advances in Experimental Medicine and Biology. 741: 171-86. PMID 22457110 DOI: 10.1007/978-1-4614-2098-9_12  1
2012 Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). International Journal of Oncology. 41: 5-14. PMID 22446714 DOI: 10.3892/Ijo.2012.1414  1
2012 Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World Journal of Clinical Oncology. 3: 32-42. PMID 22442756 DOI: 10.5306/Wjco.V3.I3.32  1
2012 Hamada T, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma. Cancer. 118: 5251-64. PMID 22434549 DOI: 10.1002/Cncr.27542  1
2012 Mimeault M, Johansson SL, Batra SK. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies. Plos One. 7: e31919. PMID 22384099 DOI: 10.1371/Journal.Pone.0031919  1
2012 Torres MP, Chakraborty S, Souchek J, Batra SK. Mucin-based targeted pancreatic cancer therapy. Current Pharmaceutical Design. 18: 2472-81. PMID 22372499 DOI: 10.2174/13816128112092472  1
2012 Tarang S, Kumar S, Batra SK. Mucins and toll-like receptors: kith and kin in infection and cancer. Cancer Letters. 321: 110-9. PMID 22306702 DOI: 10.1016/J.Canlet.2012.01.040  1
2012 Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK, Yonezawa S. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 79: 101-6. PMID 22286058 DOI: 10.1159/000335164  1
2012 Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opinion On Therapeutic Targets. 16: 15-31. PMID 22239438 DOI: 10.1517/14728222.2011.648617  1
2012 Senapati S, Gnanapragassam VS, Moniaux N, Momi N, Batra SK. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 31: 3346-56. PMID 22105367 DOI: 10.1038/Onc.2011.505  1
2012 Kaur S, Venktaraman G, Jain M, Senapati S, Garg PK, Batra SK. Recent trends in antibody-based oncologic imaging. Cancer Letters. 315: 97-111. PMID 22104729 DOI: 10.1016/J.Canlet.2011.10.017  1
2012 Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K. MUC4: a novel prognostic factor of oral squamous cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 130: 1768-76. PMID 21618516 DOI: 10.1002/Ijc.26187  1
2012 Senapati S, Batra S, Chakraborty S, Nath I, Panda S, Patra R. Non-human prostate cancer cell lines Oncology, Gastroenterology and Hepatology Reports. 1: 15. DOI: 10.4103/2348-3113.133625  0.01
2012 Ganti AK, Kaur S, West WW, Dhangada Majhi P, Lakshmanan I, Smith L, Rolle CE, Carey G, Sharma P, Salgia R, Batra S. MUC4 expression in non-small cell lung cancer. Journal of Clinical Oncology. 30: e17549-e17549. DOI: 10.1200/Jco.2012.30.15_Suppl.E17549  0.01
2012 Lin W, Rajbhandari N, Liu C, Sakamoto K, Batra S, Opavsky R, Felsher D, Hollingsworth M, Hebrok M, Rui H, Wagner K. Abstract LB-429: Dormant cancer cells contribute to residual disease in a mouse model for reversible pancreatic cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-429  1
2012 Niv Y, Boltin D, Halpern M, Cohen M, Levi Z, Vilkin A, Morgenstern S, Gagneux P, Batra SK, Ho SB. Su1610 Membrane-Bound Mucins Expression in Helicobacter pylori, NSAID, and Idiopathic Peptic Ulcers Gastroenterology. 142: S-463. DOI: 10.1016/S0016-5085(12)61754-5  0.01
2012 Baine M, Lester K, Lin C, Chen S, Kaur S, Sahak F, Batra SK. Unbiased Analysis of Pancreatic Cancer Radiation Resistance Reveals Cholesterol Biosynthesis as a Potent Novel Target for Radiosensitization International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.430  1
2012 Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK. Erratum: High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis (International Journal of Cancer (2010) 127 (1373-1383) DOI: 10.1002/ijc.25166) International Journal of Cancer. 130. DOI: 10.1002/Ijc.27492  1
2012 Batra SK, Pourdeyhimi B. Introduction to nonwovens technology Textile World. 162.  1
2011 Hauke RJ, Tarantolo SR, Batra S, Chakraborty S. Second primary cancers and their prognostic significance in patients with renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 377. PMID 27968511 DOI: 10.1200/Jco.2011.29.7_Suppl.377  1
2011 Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/Cncr.25803  1
2011 Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 11: 1-14. PMID 22820136 DOI: 10.3233/Cbm-2012-0260  1
2011 Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Pathobiological implications of MUC16 expression in pancreatic cancer. Plos One. 6: e26839. PMID 22066010 DOI: 10.1371/Journal.Pone.0026839  1
2011 Dey P, Ponnusamy MP, Deb S, Batra SK. Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer. Plos One. 6: e26926. PMID 22046413 DOI: 10.1371/Journal.Pone.0026926  1
2011 Jain M, Venkatraman G, Moniaux N, Kaur S, Kumar S, Chakraborty S, Varshney GC, Batra SK. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. Plos One. 6: e23344. PMID 21886786 DOI: 10.1371/Journal.Pone.0023344  1
2011 Mimeault M, Batra SK. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine. 6: 31. PMID 21859497 DOI: 10.1186/1749-8546-6-31  1
2011 Lakshmanan I, Ponnusamy MP, Das S, Chakraborty S, Haridas D, Mukhopadhyay P, Lele SM, Batra SK. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene. 31: 805-17. PMID 21785467 DOI: 10.1038/Onc.2011.297  0.01
2011 Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. Plos One. 6: e21052. PMID 21698253 DOI: 10.1371/Journal.Pone.0021052  1
2011 Chakraborty S, Tarantolo SR, Treves J, Sambol D, Hauke RJ, Batra SK. Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab. Case Reports in Oncology. 4: 136-42. PMID 21691572 DOI: 10.1159/000326851  1
2011 Mimeault M, Batra SK. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. Brain Pathology (Zurich, Switzerland). 21: 479-500. PMID 21615592 DOI: 10.1111/J.1750-3639.2011.00505.X  1
2011 Mimeault M, Batra SK. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Molecular Medicine (Cambridge, Mass.). 17: 949-64. PMID 21607288 DOI: 10.2119/Molmed.2011.00115  1
2011 Ponnusamy MP, Seshacharyulu P, Vaz A, Dey P, Batra SK. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. Journal of Ovarian Research. 4: 7. PMID 21521521 DOI: 10.1186/1757-2215-4-7  1
2011 Mimeault M, Batra SK. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells. Biochimica Et Biophysica Acta. 1816: 25-37. PMID 21396984 DOI: 10.1016/J.Bbcan.2011.03.001  1
2011 Resta-Lenert S, Das S, Batra SK, Ho SB. Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity. American Journal of Physiology. Gastrointestinal and Liver Physiology. 300: G1144-55. PMID 21393431 DOI: 10.1152/Ajpgi.00138.2010  1
2011 Wang G, Lipert RJ, Jain M, Kaur S, Chakraboty S, Torres MP, Batra SK, Brand RE, Porter MD. Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scattering. Analytical Chemistry. 83: 2554-61. PMID 21391573 DOI: 10.1021/Ac102829B  1
2011 Rachagani S, Senapati S, Chakraborty S, Ponnusamy MP, Kumar S, Smith LM, Jain M, Batra SK. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. British Journal of Cancer. 104: 1038-48. PMID 21364589 DOI: 10.1038/Bjc.2011.31  0.01
2011 Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. Plos One. 6: e17014. PMID 21347333 DOI: 10.1371/Journal.Pone.0017014  1
2011 Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochimica Et Biophysica Acta. 1815: 224-40. PMID 21277939 DOI: 10.1016/J.Bbcan.2011.01.001  1
2011 Chakraborty S, Bonthu N, Swanson BJ, Batra SK. Role of mucins in the skin during benign and malignant conditions. Cancer Letters. 301: 127-41. PMID 21146919 DOI: 10.1016/J.Canlet.2010.11.004  1
2011 Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK. Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 267-74. PMID 21059814 DOI: 10.1158/1078-0432.Ccr-10-1937  1
2011 Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Goto M, Batra SK, Yonezawa S. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression. Glycobiology. 21: 247-56. PMID 20926598 DOI: 10.1093/Glycob/Cwq155  1
2011 Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 44-64. PMID 20888394 DOI: 10.1016/J.Bbcan.2010.09.002  1
2011 Deb S, Ponnusamy MP, Batra SK. PAF1 (Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44536  1
2011 Senapati S, Singh AP, Batra SK. GDF15 (growth differentiation factor 15) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44426  1
2011 Junker W, Moniaux N, Batra S. MUC17 (mucin 17, cell surface associated) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/38526  1
2011 Senapati S, Ponnusamy M, Singh A, Jain M, Batra S. MUC16 (mucin 16, cell surface associated) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/38525  1
2011 Moniaux N, Chaturvedi P, Van SI, Porchet N, Singh A, Batra S. MUC4 (mucin 4, cell surface associated) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/38441  1
2011 Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Goto M, Batra SK, Yonezawa S. Abstract 82: Expression of MUC17, a marker of pancreatic cancer, is under the control of epigenetic modifications Cancer Research. 71: 82-82. DOI: 10.1158/1538-7445.Am2011-82  1
2011 Tong Z, Chakraborty S, Sung B, Kaur S, Aggarwal BB, Mani S, Bresalier RS, Batra S, Guha S. Abstract 5008: Epidermal growth factor downregulates expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells Cancer Research. 71: 5008-5008. DOI: 10.1158/1538-7445.Am2011-5008  1
2011 Lin W, Zhang Q, Opavsky R, DiMaio DJ, Felsher DW, Batra SK, Hollingsworth MA, Wagner K. Abstract 2384: A novel mouse model for the study of c-MYC during initiation and progression of pancreatic ductal adenocarcinoma Cancer Research. 71: 2384-2384. DOI: 10.1158/1538-7445.Am2011-2384  1
2011 Li K, Lee A, Kandarian BS, Manugian V, Peterson MR, Batra SK, Ho SB. Aberrant Expression of MUC17 Correlates With Survival in Advanced Stage Colorectal Adenocarcinomas Gastroenterology. 140: S-345. DOI: 10.1016/S0016-5085(11)61402-9  0.01
2011 Mimeault M, Batra SK. Stem cell applications in disease research: Recent advances in stem cell and cancer stem cell biology and their therapeutic implications Stem Cell Research Journal. 3: 349-388.  1
2011 Mimeault M, Batra SK. Novel diagnostic and prognostic biomarkers and molecular therapeutic targets in aggressive, metastatic and recurrent melanomas Metastatic Melanoma: Symptoms, Diagnoses and Treatments. 127-148.  1
2011 Mimeault M, Batra SK. Recent progress and related patents on the applications of bone marrow-derived stem/progenitor cells in regenerative medicine and cancer therapies Recent Patents On Regenerative Medicine. 1: 42-59.  1
2010 Mimeault M, Batra SK. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacological Reviews. 62: 497-524. PMID 20716670 DOI: 10.1124/Pr.109.002329  1
2010 Senapati S, Ho SB, Sharma P, Das S, Chakraborty S, Kaur S, Niehans G, Batra SK. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Journal of Clinical Pathology. 63: 702-7. PMID 20702471 DOI: 10.1136/Jcp.2010.078717  1
2010 Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene. 29: 5741-54. PMID 20697346 DOI: 10.1038/Onc.2010.309  1
2010 Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: Role of estrogens Expert Review of Respiratory Medicine. 4: 509-518. PMID 20658912 DOI: 10.1586/Ers.10.50  1
2010 Togami S, Nomoto M, Higashi M, Goto M, Yonezawa S, Tsuji T, Batra SK, Douchi T. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix. The Journal of Obstetrics and Gynaecology Research. 36: 588-97. PMID 20598042 DOI: 10.1111/J.1447-0756.2010.01221.X  1
2010 Chakraborty S, Swanson BJ, Bonthu N, Batra SK. Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases. Journal of Clinical Pathology. 63: 579-84. PMID 20591909 DOI: 10.1136/Jcp.2010.076125  1
2010 Murielle M, Batra SK. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer Journal of Cellular Physiology. 224: 626-635. PMID 20578239 DOI: 10.1002/Jcp.22196  1
2010 Mimeault M, Batra SK. New advances on critical implications of tumorand metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence Histology and Histopathology. 25: 1057-1073. PMID 20552555 DOI: 10.14670/Hh-25.1057  1
2010 Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. The Journal of Biological Chemistry. 285: 23598-606. PMID 20498373 DOI: 10.1074/Jbc.M109.098301  1
2010 Deng M, Chen PC, Xie S, Zhao J, Gong L, Liu J, Zhang L, Sun S, Liu J, Ma H, Batra SK, Li DW. The small heat shock protein alphaA-crystallin is expressed in pancreas and acts as a negative regulator of carcinogenesis. Biochimica Et Biophysica Acta. 1802: 621-31. PMID 20434541 DOI: 10.1016/J.Bbadis.2010.04.004  1
2010 Torres MP, Ponnusamy MP, Chakraborty S, Smith LM, Das S, Arafat HA, Batra SK. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: Implications for the development of novel cancer therapies Molecular Cancer Therapeutics. 9: 1419-1431. PMID 20423995 DOI: 10.1158/1535-7163.Mct-10-0075  1
2010 Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 29: 2893-904. PMID 20348949 DOI: 10.1038/Onc.2010.87  1
2010 Mimeault M, Batra SK. Recent advancements on the identification of immature cancer cells with the stem cell-like properties in different aggressive and recurrent cancer types Anti-Cancer Agents in Medicinal Chemistry. 10: 103. PMID 20344823 DOI: 10.2174/187152010790909335  1
2010 Mimeault M, Batra SK. New promising drug targets in cancer- and mtastasis-initiating cells Drug Discovery Today. 15: 354-364. PMID 20338259 DOI: 10.1016/J.Drudis.2010.03.009  1
2010 Ho SB, Luu Y, Shekels LL, Batra SK, Kandarian B, Evans DB, Zaworski PG, Wolfe CL, Heinrikson RL. Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins. Biochimica Et Biophysica Acta. 1800: 629-38. PMID 20332014 DOI: 10.1016/J.Bbagen.2010.03.010  1
2010 Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters. 295: 69-84. PMID 20303649 DOI: 10.1016/J.Canlet.2010.02.015  1
2010 Luu Y, Junker W, Rachagani S, Das S, Batra SK, Heinrikson RL, Shekels LL, Ho SB. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis International Journal of Biochemistry and Cell Biology. 42: 996-1006. PMID 20211273 DOI: 10.1016/J.Biocel.2010.03.001  1
2010 Mimeault M, Batra SK. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies Anti-Cancer Agents in Medicinal Chemistry. 10: 137-151. PMID 20184544 DOI: 10.2174/187152010790909353  1
2010 Chakraborty S, Kaur S, Muddana V, Sharma N, Wittel UA, Papachristou GI, Whitcomb D, Brand RE, Batra SK. Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis American Journal of Gastroenterology. 105: 2050-2059. PMID 20179686 DOI: 10.1038/Ajg.2010.23  1
2010 Mimeault M, Johansson SL, Henichart JP, Depreux P, Batra SK. Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells. Molecular Cancer Therapeutics. 9: 617-30. PMID 20179163 DOI: 10.1158/1535-7163.Mct-09-1013  1
2010 Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. International Journal of Cancer. Journal International Du Cancer. 127: 1373-83. PMID 20073063 DOI: 10.1002/Ijc.25166  1
2010 Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications Cancer Letters. 292: 8-16. PMID 20004512 DOI: 10.1016/J.Canlet.2009.11.010  1
2010 Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene. 29: 1293-302. PMID 19946339 DOI: 10.1038/Onc.2009.420  1
2010 Senapati S, Das S, Batra SK. Mucin-interacting proteins: From function to therapeutics Trends in Biochemical Sciences. 35: 236-245. PMID 19913432 DOI: 10.1016/J.Tibs.2009.10.003  1
2010 Higashi M, Goto M, Saitou M, Shimizu T, Rousseau K, Batra SK, Yonezawa S. Immunohistochemical study of mucin expression in periampullary adenomyoma. Journal of Hepato-Biliary-Pancreatic Sciences. 17: 275-83. PMID 19784541 DOI: 10.1007/S00534-009-0176-5  1
2010 Mimeault M, Batra SK. Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies Journal of Cellular and Molecular Medicine. 14: 116-134. PMID 19725922 DOI: 10.1111/J.1582-4934.2009.00885.X  1
2010 Chakraborty S, Baine M, Kaur S, Mallya K, Jain M, Sasson AR, Batra SK. Abstract LB-212: Elevated plasma NGAL and MIC-1 are novel biomarkers for the diagnosis of pancreatic adenocarcinoma Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-212  1
2010 Torres MP, Ponnusamy MP, Chakraborty S, Arafat HA, Batra SK. Abstract 766: Downregulation of MUC4 in pancreatic cancer cells by thymoquinone: A promise for pancreatic cancer therapies Cancer Research. 70: 766-766. DOI: 10.1158/1538-7445.Am10-766  1
2010 Souchek JJ, Chakraborty S, Rachagani S, Hauke R, Batra SK. Abstract 722: Reciprocal regulation of MUC4 and HER-2 by the corticosteroid fluticasone propionate in pancreatic cancer cells: Potential role in anticancer therapy Cancer Research. 70: 722-722. DOI: 10.1158/1538-7445.Am10-722  1
2010 Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Abstract 5180: MUC4 mucin upregulates N-cadherin: A novel mechanism for human ovarian tumor metastasis Cancer Research. 70: 5180-5180. DOI: 10.1158/1538-7445.Am10-5180  1
2010 Momi N, Ponnusamy MP, Batra SK. Abstract 431: Cigarette-smoke-induced expression of MUC4 in human pancreatic cancer cells: Potential pathological roles Cancer Research. 70: 431-431. DOI: 10.1158/1538-7445.Am10-431  1
2010 Xiao Y, Gao X, Cheung W, Urbas A, Taratula O, Holbrook D, Cavicchi RE, Souchek JJ, Wagner PD, Srivastava S, Avedisian T, He H, Batra S. Abstract 3686: Antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast and pancreas cancer cells Cancer Research. 70: 3686-3686. DOI: 10.1158/1538-7445.Am10-3686  1
2010 Dey P, Chakraborty S, Senapati S, Basavaraju GC, Band V, Batra SK. Abstract 36: Human ecdysoneless protein: Regulator of cholesterol homeostasis in pancreatic cancer Cancer Research. 70: 36-36. DOI: 10.1158/1538-7445.Am10-36  1
2010 Das S, Ponnusamy MP, Johansson SL, Senapati S, Pandey P, Roy HK, Batra SK. Abstract 3075: MUC4 mucin as a potential tumor suppressor in colon cancer Cancer Research. 70: 3075-3075. DOI: 10.1158/1538-7445.Am10-3075  1
2010 Kunigal SS, Batra SK, Chellappan SP. Abstract 2948: Nicotine-induced expression of MUC4 in pancreatic cancer cells is mediated by E2F1 and STAT-1 upregulation: Relevance to smoking and pancreatic cancer Cancer Research. 70: 2948-2948. DOI: 10.1158/1538-7445.Am10-2948  1
2010 Baine M, Chakraborty S, Smith L, Mallya K, Sasson A, Batra S. Abstract 1980: Transcriptional profiling in peripheral blood mononuclear cells of patients with pancreatic cancer identifies several genes with potential diagnostic and prognostic implications Cancer Research. 70: 1980-1980. DOI: 10.1158/1538-7445.Am10-1980  1
2010 Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. Erratum: MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells (Oncogene (2010) 29 (5741-5754) DOI: 10.1038/onc.2010.309) Oncogene. 29. DOI: 10.1038/Onc.2010.472  1
2010 Tiwari AK, Kunte D, Wali RK, Ward TP, DeLaCruz M, Gandhi SR, Senapati S, Das S, Stypula Y, Batra SK, Roy HK. W1747 MUC4 and AKT/β-Catenin Mediated Control of Cell Proliferation in Early Colon Carcinogenesis Gastroenterology. 138: S-731-S-732. DOI: 10.1016/S0016-5085(10)63367-7  0.01
2010 Kunte D, Batra SK, Das S, Senapati S, Wali RK, Tiwari AK, Ward TP, DeLaCruz M, Gandhi SR, Roy HK. S1951 MUC 4 Suppression is an Early Event in Colorectal Carcinogenesis (CRC): Potential Biomarker for Screening and Chemoprevention Gastroenterology. 138: S-287-S-288. DOI: 10.1016/S0016-5085(10)61322-4  0.01
2010 Shantibhusan S, Ho SB, Sharma P, Das S, Chakraborty S, Kaur S, Resta SC, Kandarian BS, Batra SK. S1681 Expression of Intestinal MUC17 Membrane-Bound Mucin in Inflammatory and Neoplastic Diseases of the Colon Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)61151-1  1
2010 Tiwari AK, Kunte D, Ward TP, DeLaCruz M, Gandhi SR, Wali R, Batra SK, Roy HK. S1673 Mechanisms of CDx2 Suppression in Colorectal Carcinogenesis: Role of Deoxycholate-MUC 4 Signaling Cascade Gastroenterology. 138: S-250-S-251. DOI: 10.1016/S0016-5085(10)61143-2  0.01
2010 Mimeault M, Batra SK. Anti-Cancer Agents in Medicinal Chemistry: Editorial Anti-Cancer Agents in Medicinal Chemistry. 10: 103.  1
2010 Virmani M, Garg SL, Virmani N, Batra SK. Activity of extracts of Synzium aromaticum against microbes of veterinary importance Indian Journal of Animal Sciences. 80: 284-288.  1
2009 Rachagani S, Torres MP, Moniaux N, Batra SK. Current status of mucins in the diagnosis and therapy of cancer Biofactors. 35: 509-527. PMID 19904814 DOI: 10.1002/Biof.64  1
2009 Ponnusamy MP, Deb S, Dey P, Chakraborty S, Rachagani S, Senapati S, Batra SK. RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 3001-11. PMID 19821493 DOI: 10.1002/Stem.237  1
2009 Mimeault M, Batra SK. Aging of tissue-resident adult stem/progenitor cells and their pathological consequences Panminerva Medica. 51: 57-79. PMID 19776709  1
2009 Moniaux N, Nemos C, Deb S, Zhu B, Dornreiter I, Hollingsworth MA, Batra SK. The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression. Plos One. 4: e7077. PMID 19771162 DOI: 10.1371/Journal.Pone.0007077  1
2009 Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. British Journal of Cancer. 101: 1155-61. PMID 19738614 DOI: 10.1038/Sj.Bjc.6605285  1
2009 Mimeault M, Batra SK. Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method Methods in Molecular Biology (Clifton, N.J.). 568: 139-149. PMID 19582424 DOI: 10.1007/978-1-59745-280-9_8  1
2009 Zhang L, Davis JS, Zelivianski S, Lin FF, Schutte R, Davis TL, Hauke R, Batra SK, Lin MF. Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. Cancer Letters. 285: 58-65. PMID 19467571 DOI: 10.1016/J.Canlet.2009.04.041  1
2009 Chipitsyna G, Gong Q, Anandanadesan R, Alnajar A, Batra SK, Wittel UA, Cullen DM, Akhter MP, Denhardt DT, Yeo CJ, Arafat HA. Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. International Journal of Cancer. 125: 276-85. PMID 19358273 DOI: 10.1002/Ijc.24388  1
2009 Munro EG, Jain M, Oliva E, Kamal N, Lele SM, Lynch MP, Guo L, Fu K, Sharma P, Remmenga S, Growdon WB, Davis JS, Rueda BR, Batra SK. Upregulation of MUC4 in cervical squamous cell carcinoma: pathologic significance. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 28: 127-33. PMID 19188823 DOI: 10.1097/Pgp.0B013E318184F3E0  1
2009 Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications Ageing Research Reviews. 8: 94-112. PMID 19114129 DOI: 10.1016/J.Arr.2008.12.001  1
2009 Kunte D, Weber CR, Batra SK, Das S, Senapati S, Wali RK, Koetsier J, Roy HK. W1878 Muc4: A Novel Tumor Suppressor Gene Impacts Upon Initiation and Progression Phases of Colorectal Carcinogenesis Gastroenterology. 136: A-745. DOI: 10.1016/S0016-5085(09)63437-5  0.01
2009 Muddana V, Papachristou GI, Chakraborty S, Kaur S, Sharma N, Whitcomb DC, Brand R, Batra SK. T1300 Serum Neutrophil-Associated Gelatinase Lipocalcin (NGAL) Levels As An Early Biomarker of Severe Acute Pancreatitis Gastroenterology. 136: A-543. DOI: 10.1016/S0016-5085(09)62495-1  0.01
2009 Resta SC, Luu YH, Junker WM, Rachagani S, Moore ED, Batra SK, Ho SB. M1697 The Membrane Bound MUC17 Mucin Protects Cell Integrity in Response to Short Term Infection with Enteroinvasive E. coli Gastroenterology. 136: A-412-A-413. DOI: 10.1016/S0016-5085(09)61897-7  0.01
2009 Kunte D, Weber CR, Batra SK, Das S, Senapati S, Wali RK, Koetsier J, Roy HK. S2044 MUC17: A Novel Tumor Suppressor Gene in Colon Carcinogenesis? Gastroenterology. 136: A-319. DOI: 10.1016/S0016-5085(09)61459-1  0.01
2009 Mimeault M, Batra SK. Potential molecular therapeutic targets in cancer stem/progenitor cells: Are ATP-binding cassette membrane transporters appropriate targets to eliminate cancer-initiating cells? Stem Cell Biology in Health and Disease. 385-421. DOI: 10.1007/978-90-481-3040-5_17  1
2008 Deb S, Ponnusamy MP, Senapati S, Dey P, Batra SK. Human PAF complexes in endocrine tumors and pancreatic cancer. Expert Review of Endocrinology & Metabolism. 3: 557-565. PMID 30290411 DOI: 10.1586/17446651.3.5.557  1
2008 Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer. Expert Opinion On Medical Diagnostics. 2: 891-910. PMID 23495864 DOI: 10.1517/17530059.2.8.891  1
2008 Ponnusamy MP, Batra SK. Ovarian cancer: emerging concept on cancer stem cells. Journal of Ovarian Research. 1: 4. PMID 19014671 DOI: 10.1186/1757-2215-1-4  0.01
2008 Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS, Remmenga S, Batra SK. Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. The Lancet. Oncology. 9: 1076-85. PMID 19012856 DOI: 10.1016/S1470-2045(08)70277-8  1
2008 Bafna S, Singh AP, Moniaux N, Eudy JD, Meza JL, Batra SK. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Research. 68: 9231-8. PMID 19010895 DOI: 10.1158/0008-5472.Can-08-3135  1
2008 Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histology and Histopathology. 23: 1541-52. PMID 18830939 DOI: 10.14670/Hh-23.1541  1
2008 Mimeault M, Batra SK. Recent progress on normal and malignant pancreatic stem/progenitor cell research: Therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut. 57: 1456-1468. PMID 18791122 DOI: 10.1136/gut.2008.150052  1
2008 Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. British Journal of Cancer. 99: 949-56. PMID 18781152 DOI: 10.1038/Sj.Bjc.6604632  1
2008 Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. British Journal of Cancer. 99: 520-6. PMID 18665193 DOI: 10.1038/Sj.Bjc.6604517  0.04
2008 Matull WR, Andreola F, Loh A, Adiguzel Z, Deheragoda M, Qureshi U, Batra SK, Swallow DM, Pereira SP. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. British Journal of Cancer. 98: 1675-81. PMID 18475301 DOI: 10.1038/Sj.Bjc.6604364  0.01
2008 Mimeault M, Batra SK. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: The ultimate hope for treating and curing aggressive and recurrent cancers Panminerva Medica. 50: 3-18. PMID 18427384  1
2008 Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. British Journal of Cancer. 98: 1540-7. PMID 18392050 DOI: 10.1038/Sj.Bjc.6604329  1
2008 Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 68: 2065-70. PMID 18381409 DOI: 10.1158/0008-5472.Can-07-6041  1
2008 Wittel UA, Wiech T, Chakraborty S, Boss B, Lauch R, Batra SK, Hopt UT. Taurocholate-induced pancreatitis: A model of severe necrotizing pancreatitis in mice Pancreas. 36. PMID 18376298 DOI: 10.1097/Mpa.0B013E3181575103  1
2008 Mimeault M, Mehta PP, Hauke R, Batra SK. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocrine Reviews. 29: 234-52. PMID 18292464 DOI: 10.1210/Er.2007-0040  1
2008 Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications Stem Cell Reviews. 4: 27-49. PMID 18288619 DOI: 10.1007/S12015-008-9008-2  1
2008 Davda JP, Jain M, Batra SK, Gwilt PR, Robinson DH. A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs. International Immunopharmacology. 8: 401-13. PMID 18279794 DOI: 10.1016/J.Intimp.2007.10.023  1
2008 Wittel UA, Hopt UT, Batra SK. Cigarette smoke-induced pancreatic damage - Experimental data Langenbeck's Archives of Surgery. 393: 581-588. PMID 18193450 DOI: 10.1007/S00423-007-0273-3  1
2008 Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 966-81. PMID 18024835 DOI: 10.1096/Fj.07-9673Rev  1
2008 Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Letters. 259: 28-38. PMID 17977648 DOI: 10.1016/J.Canlet.2007.09.018  1
2008 Mimeault M, Hauke R, Batra SK. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Clinical Pharmacology and Therapeutics. 83: 673-691. PMID 17786164 DOI: 10.1038/Sj.Clpt.6100296  1
2008 Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer Expert Opinion On Medical Diagnostics. 2: 891-910. DOI: 10.1517/17530059.2.8.891  1
2008 Krishnan P, Singh H, Batra S. A Case Report of Villous Adenoma of the Terminal Ileum Masquerading as Crohnʼs Disease American Journal of Gastroenterology. 103: S298-S299. DOI: 10.14309/00000434-200809001-00759  0.01
2008 Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells (Cancer Research (April 1, 2008) 68(2065-2070)) Cancer Research. 68: 3549. DOI: 10.1158/0008-5472.Can-68-9-Cor3  1
2008 Kunte D, Batra SK, Smyrk TC, Wali RK, Koetsier J, Kraker G, Roy HK. W1097 Muc4: A Potential Tumor Suppressor Gene in Colon Carcinogenesis Gastroenterology. 134: A-632. DOI: 10.1016/S0016-5085(08)62953-4  0.01
2008 Mimeault M, Batra SK. Recent advances in the development of novel anti-cancer drugs targeting cancer stem/progenitor cells Drug Development Research. 69: 415-430. DOI: 10.1002/Ddr.20273  1
2007 Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK. Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades. Growth Factors (Chur, Switzerland). 25: 400-16. PMID 18365871 DOI: 10.1080/08977190801930935  1
2007 Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers: Stem Cells Review Series Journal of Cellular and Molecular Medicine. 11: 981-1011. PMID 17979879 DOI: 10.1111/J.1582-4934.2007.00088.X  1
2007 Mimeault M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics - Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies Clinical Pharmacology and Therapeutics. 82: 252-264. PMID 17671448 DOI: 10.1038/Sj.Clpt.6100301  1
2007 Chaudhary K, Deb S, Moniaux N, Ponnusamy MP, Batra SK. Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene. 26: 7499-507. PMID 17599057 DOI: 10.1038/Sj.Onc.1210582  1
2007 Moniaux N, Chaturvedi P, Varshney GC, Meza JL, Rodriguez-Sierra JF, Aubert JP, Batra SK. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. British Journal of Cancer. 97: 345-57. PMID 17595659 DOI: 10.1038/Sj.Bjc.6603868  1
2007 Andrianifahanana M, Singh AP, Nemos C, Ponnusamy MP, Moniaux N, Mehta PP, Varshney GC, Batra SK. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene. 26: 7251-61. PMID 17525742 DOI: 10.1038/Sj.Onc.1210532  1
2007 Jain M, Kamal N, Batra SK. Engineering antibodies for clinical applications Trends in Biotechnology. 25: 307-316. PMID 17512622 DOI: 10.1016/J.Tibtech.2007.05.001  1
2007 Jain M, Venkatraman G, Batra SK. Cell-penetrating peptides and antibodies: A new direction for optimizing radioimmunotherapy European Journal of Nuclear Medicine and Molecular Imaging. 34: 973-977. PMID 17453198 DOI: 10.1007/S00259-007-0395-4  1
2007 Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Molecular Cancer Research : McR. 5: 309-20. PMID 17406026 DOI: 10.1158/1541-7786.Mcr-06-0353  1
2007 Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Molecular Cancer Therapeutics. 6: 967-78. PMID 17363490 DOI: 10.1158/1535-7163.Mct-06-0648  1
2007 Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies Annals of Oncology. 18: 1605-1619. PMID 17355951 DOI: 10.1093/Annonc/Mdm070  1
2007 Jain M, Venkatraman G, Batra SK. Optimization of radioimmunotherapy of solid tumors: Biological impediments and their modulation Clinical Cancer Research. 13: 1374-1382. PMID 17309914 DOI: 10.1158/1078-0432.Ccr-06-2436  1
Show low-probability matches.